Quiver News

$1,550,000 of UNITED AIRLINES INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Customer-related issues. Air Traffic Control Reform, Staffing, and Modernization. Government Shutdown Impacts on Federal Aviation Administration. DOT and FAA Regulations. S. 1045/H.R. 5455, Aviation Funding Stability Act, to provide funding for the FAA in the event of a lapse in appropriations. H.R. 6086, Aviation Funding Solvency Act, to provide funding for the FAA in the event of a lapse in appropriations. S. 697, Air Traffic Control Workforce Development Act of 2025, all provisions. S. 1985, Safe Operations of Shared Airspace Act of 2025, most provisions. H.R. 3530, Flight Education Access Act, all provisions. H.R. 2591/S. 3257, Mental Health in Aviation Act of 2025, all provisions. H.R. 2592, Aviation Medication Transparency Act of 2025, all provisions. P.L. 118-63, FAA Reauthorization Act of 2024, most provisions. Credit Card Competition Act (no current bill number). H.R. 1719/S. 144, Farm to Fly Act of 2025, all provisions. S. 1422, Fanner First Fuel Incentives Act, provisions related to aviation. S. 2503, ROTOR Act, all provisions. H.R. 6518, SAF Act, all provisions. Issues pertaining to security screening and biometric technology. Issues pertaining to cabotage regulations. Issues pertaining to airline frequent flyer programs. Issues pertaining to airline workforce and labor. Issues pertaining to FCC spectrum auction/aircraft radio altimeter interference. Issues pertaining to Department of State Travel Advisory Requirements. Budget Reconciliation - Air Traffic Controller Staffing. Budget and appropriations related to the airline industry for Fiscal Year 2025 and Fiscal Year 2026. Issues pertaining to Aviation taxes and fees. Issues pertaining to Sustainable Aviation Fuels. Issues pertaining to Sustainable Aviation Fuels."

You can find more data on corporate lobbying on Quiver Quantitative.

UAL Congressional Stock Trading

Members of Congress have traded $UAL stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UAL stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/19 and 1 sale worth up to $15,000 on 02/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UAL Insider Trading Activity

UAL insiders have traded $UAL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $UAL stock by insiders over the last 6 months:

• J SCOTT KIRBY (Chief Executive Officer) sold 120,000 shares for an estimated $12,943,800
• BRETT J HART (President) sold 19,000 shares for an estimated $2,022,568

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UAL Hedge Fund Activity

We have seen 546 institutional investors add shares of UAL stock to their portfolio, and 458 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL INTERNATIONAL INVESTORS removed 3,815,497 shares (-17.3%) from their portfolio in Q4 2025, for an estimated $426,648,874
• BALYASNY ASSET MANAGEMENT L.P. removed 2,641,208 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $295,339,878
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,048,224 shares (-72.5%) from their portfolio in Q4 2025, for an estimated $229,032,407
• PRIMECAP MANAGEMENT CO/CA/ removed 2,024,470 shares (-11.2%) from their portfolio in Q4 2025, for an estimated $226,376,235
• FMR LLC added 1,857,987 shares (+12.8%) to their portfolio in Q4 2025, for an estimated $207,760,106
• HOLOCENE ADVISORS, LP removed 1,491,352 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $166,762,980
• TWO SIGMA INVESTMENTS, LP added 1,305,748 shares (+3647.3%) to their portfolio in Q4 2025, for an estimated $146,008,741

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UAL Analyst Ratings

Wall Street analysts have issued reports on $UAL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 01/22/2026
• Barclays issued a "Overweight" rating on 01/12/2026
• UBS issued a "Buy" rating on 01/06/2026
• Wells Fargo issued a "Overweight" rating on 12/18/2025
• BMO Capital issued a "Outperform" rating on 12/09/2025
• Susquehanna issued a "Positive" rating on 10/03/2025
• Jefferies issued a "Buy" rating on 10/01/2025

To track analyst ratings and price targets for UAL, check out Quiver Quantitative's $UAL forecast page.

UAL Price Targets

Multiple analysts have issued price targets for $UAL recently. We have seen 15 analysts offer price targets for $UAL in the last 6 months, with a median target of $130.0.

Here are some recent targets:

• Sheila Kahyaoglu from Jefferies set a target price of $125.0 on 03/12/2026
• Duane Pfennigwerth from Evercore ISI Group set a target price of $125.0 on 03/12/2026
• Tom Fitzgerald from TD Cowen set a target price of $128.0 on 03/09/2026
• James Goodall from Rothschild & Co set a target price of $110.0 on 03/05/2026
• Atul Maheswari from UBS set a target price of $147.0 on 01/22/2026
• John Staszak from Argus Research set a target price of $135.0 on 01/22/2026
• Catherine O'Brien from Goldman Sachs set a target price of $129.0 on 01/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$250,000 of BRIGHTSPRING HEALTH SERVICES lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Long-term care pharmacy and other pharmacy issues HR 5130/S 3159, IRA implementation issues included), Medicare payment rules including hospice, home health and physician fee schedule (HR 5142 included), home infusion fix, Medicaid regulations, workforce development Long-term care pharmacy fix, IRA implementation"

You can find more data on corporate lobbying on Quiver Quantitative.

BTSG Insider Trading Activity

BTSG insiders have traded $BTSG stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $BTSG stock by insiders over the last 6 months:

• GROUP PARTNERSHIP L.P. KKR has made 0 purchases and 2 sales selling 34,460,000 shares for an estimated $1,231,936,705.
• PHOENIX AGGREGATOR L.P. KKR has made 0 purchases and 2 sales selling 34,460,000 shares for an estimated $1,231,936,705.
• JON B ROUSSEAU (See Remarks) has made 0 purchases and 2 sales selling 455,000 shares for an estimated $15,816,770.
• LISA A NALLEY (See Remarks) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $1,810,140.
• JENNIFER A PHIPPS (Chief Financial Officer) sold 35,000 shares for an estimated $1,440,250

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BTSG Hedge Fund Activity

We have seen 192 institutional investors add shares of BTSG stock to their portfolio, and 128 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 15,154,305 shares (-19.7%) from their portfolio in Q4 2025, for an estimated $567,528,722
• BLACKROCK, INC. added 9,372,929 shares (+123.1%) to their portfolio in Q4 2025, for an estimated $351,016,191
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,958,691 shares (-78.7%) from their portfolio in Q4 2025, for an estimated $148,252,977
• VANGUARD GROUP INC added 2,928,953 shares (+30.5%) to their portfolio in Q4 2025, for an estimated $109,689,289
• FMR LLC removed 2,325,097 shares (-9.3%) from their portfolio in Q4 2025, for an estimated $87,074,882
• ROYAL BANK OF CANADA removed 2,198,147 shares (-99.6%) from their portfolio in Q4 2025, for an estimated $82,320,605
• STATE STREET CORP added 2,011,095 shares (+99.5%) to their portfolio in Q4 2025, for an estimated $75,315,507

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BTSG Analyst Ratings

Wall Street analysts have issued reports on $BTSG in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 01/07/2026
• BTIG issued a "Buy" rating on 12/23/2025
• Stephens & Co. issued a "Overweight" rating on 12/11/2025
• William Blair issued a "Outperform" rating on 12/08/2025
• BMO Capital issued a "Outperform" rating on 11/13/2025
• Mizuho issued a "Outperform" rating on 10/17/2025
• Morgan Stanley issued a "Overweight" rating on 10/14/2025

To track analyst ratings and price targets for BTSG, check out Quiver Quantitative's $BTSG forecast page.

BTSG Price Targets

Multiple analysts have issued price targets for $BTSG recently. We have seen 9 analysts offer price targets for $BTSG in the last 6 months, with a median target of $45.0.

Here are some recent targets:

• Erin Wright from Morgan Stanley set a target price of $48.0 on 03/04/2026
• Ann Hynes from Mizuho set a target price of $50.0 on 03/03/2026
• Stephen Baxter from Wells Fargo set a target price of $50.0 on 03/02/2026
• David Larsen from BTIG set a target price of $55.0 on 03/02/2026
• Matthew Gillmor from Keybanc set a target price of $45.0 on 12/12/2025
• Dean Sublett from Stephens & Co. set a target price of $44.0 on 12/11/2025
• Joanna Gajuk from B of A Securities set a target price of $41.0 on 12/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$480,000 of CAPITAL ONE FINANCIAL CORPORATION lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.1 - One Big Beautiful Bill Act; General issues impacting the tax code, including corporate tax rate and tax credit supported programs. Issues related to antitrust General issues impacting consumer and commercial loans including payment systems, emerging payments, loan terms and product features, and the regulation of banking"

You can find more data on corporate lobbying on Quiver Quantitative.

COF Congressional Stock Trading

Members of Congress have traded $COF stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $COF stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/09 and 1 sale worth up to $15,000 on 02/10.
• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 2 purchases worth up to $200,000 on 12/29, 11/10 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

COF Insider Trading Activity

COF insiders have traded $COF stock on the open market 43 times in the past 6 months. Of those trades, 0 have been purchases and 43 have been sales.

Here’s a breakdown of recent trading of $COF stock by insiders over the last 6 months:

• RICHARD D FAIRBANK (Chairman and CEO) has made 0 purchases and 17 sales selling 206,973 shares for an estimated $46,192,770.
• NEAL BLINDE (President, Commercial Banking) has made 0 purchases and 9 sales selling 81,335 shares for an estimated $16,848,294.
• FRANK G. LAPRADE,III (Chief Enterprise Srvcs Officer) has made 0 purchases and 2 sales selling 17,840 shares for an estimated $3,961,081.
• RAVI RAGHU (Pres, Software, Intl & Sm Bus) sold 13,450 shares for an estimated $3,362,500
• LIA DEAN (Pres, Banking & Prem. Products) has made 0 purchases and 3 sales selling 9,716 shares for an estimated $2,220,576.
• MATTHEW W COOPER (General Counsel & Corp Secy) has made 0 purchases and 4 sales selling 8,000 shares for an estimated $1,805,880.
• CELIA KARAM (Pres, Retail Bank) has made 0 purchases and 3 sales selling 7,108 shares for an estimated $1,604,897.
• JASON P. HANSON (Pres.- Global Payment Network) sold 3,729 shares for an estimated $764,445
• MARK DANIEL MOUADEB (President, Card) has made 0 purchases and 3 sales selling 3,102 shares for an estimated $640,285.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

COF Hedge Fund Activity

We have seen 1,059 institutional investors add shares of COF stock to their portfolio, and 922 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 20,657,617 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $5,006,580,056
• VIKING GLOBAL INVESTORS LP removed 4,436,189 shares (-60.0%) from their portfolio in Q4 2025, for an estimated $1,075,154,766
• DODGE & COX removed 2,944,850 shares (-24.3%) from their portfolio in Q4 2025, for an estimated $713,713,846
• CAPITAL RESEARCH GLOBAL INVESTORS removed 2,538,515 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $615,234,495
• FMR LLC added 2,026,496 shares (+12.1%) to their portfolio in Q4 2025, for an estimated $491,141,570
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,887,957 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $401,341,899
• HARRIS ASSOCIATES L P added 1,800,024 shares (+19.9%) to their portfolio in Q4 2025, for an estimated $436,253,816

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

COF Analyst Ratings

Wall Street analysts have issued reports on $COF in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 01/23/2026
• Morgan Stanley issued a "Overweight" rating on 01/20/2026
• TD Cowen issued a "Buy" rating on 01/08/2026
• Barclays issued a "Overweight" rating on 01/06/2026
• Citigroup issued a "Buy" rating on 12/31/2025
• UBS issued a "Buy" rating on 10/07/2025
• Evercore ISI Group issued a "Outperform" rating on 09/30/2025

To track analyst ratings and price targets for COF, check out Quiver Quantitative's $COF forecast page.

COF Price Targets

Multiple analysts have issued price targets for $COF recently. We have seen 13 analysts offer price targets for $COF in the last 6 months, with a median target of $275.0.

Here are some recent targets:

• Brian Foran from Truist Securities set a target price of $275.0 on 01/27/2026
• Terry Ma from Barclays set a target price of $287.0 on 01/26/2026
• Vincent Caintic from BTIG set a target price of $270.0 on 01/23/2026
• Jeffrey Adelson from Morgan Stanley set a target price of $300.0 on 01/20/2026
• Richard Shane from JP Morgan set a target price of $256.0 on 01/12/2026
• Moshe Orenbuch from TD Cowen set a target price of $290.0 on 01/08/2026
• Donald Fandetti from Wells Fargo set a target price of $280.0 on 01/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of HONEYWELL INTERNATIONAL lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General outreach"

You can find more data on corporate lobbying on Quiver Quantitative.

HON Congressional Stock Trading

Members of Congress have traded $HON stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:

• SENATOR ANGUS S. KING JR. purchased up to $15,000 on 12/29.
• REPRESENTATIVE DEBBIE DINGELL sold up to $50,000 on 11/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 09/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HON Insider Trading Activity

HON insiders have traded $HON stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $HON stock by insiders over the last 6 months:

• GRACE LIEBLEIN has made 0 purchases and 3 sales selling 5,847 shares for an estimated $1,425,089.
• ROBERT D. MAILLOUX (Vice President & Controller) sold 5,274 shares for an estimated $1,260,486
• D SCOTT DAVIS sold 2,367 shares for an estimated $568,080

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HON Hedge Fund Activity

We have seen 1,112 institutional investors add shares of HON stock to their portfolio, and 1,428 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• J. STERN & CO. LLP added 52,975,716 shares (+22704.6%) to their portfolio in Q4 2025, for an estimated $10,335,032,434
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 9,237,983 shares (-71.4%) from their portfolio in Q4 2025, for an estimated $1,802,238,103
• SG AMERICAS SECURITIES, LLC added 4,046,879 shares (+36520.9%) to their portfolio in Q4 2025, for an estimated $789,505,624
• BLACKROCK, INC. added 3,582,757 shares (+7.3%) to their portfolio in Q4 2025, for an estimated $698,960,063
• BARCLAYS PLC removed 3,189,870 shares (-34.8%) from their portfolio in Q4 2025, for an estimated $622,311,738
• NOMURA HOLDINGS INC removed 3,141,472 shares (-80.0%) from their portfolio in Q4 2025, for an estimated $612,869,772
• JPMORGAN CHASE & CO removed 2,457,297 shares (-23.8%) from their portfolio in Q4 2025, for an estimated $479,394,071

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HON Analyst Ratings

Wall Street analysts have issued reports on $HON in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 01/30/2026
• JP Morgan issued a "Overweight" rating on 01/30/2026
• Citigroup issued a "Buy" rating on 01/12/2026
• B of A Securities issued a "Underperform" rating on 11/18/2025
• TD Cowen issued a "Buy" rating on 11/10/2025
• RBC Capital issued a "Outperform" rating on 10/27/2025

To track analyst ratings and price targets for HON, check out Quiver Quantitative's $HON forecast page.

HON Price Targets

Multiple analysts have issued price targets for $HON recently. We have seen 12 analysts offer price targets for $HON in the last 6 months, with a median target of $250.0.

Here are some recent targets:

• Chris Snyder from Morgan Stanley set a target price of $245.0 on 03/12/2026
• Sheila Kahyaoglu from Jefferies set a target price of $245.0 on 03/04/2026
• Julian Mitchell from Barclays set a target price of $275.0 on 03/04/2026
• Nigel Coe from Wolfe Research set a target price of $293.0 on 02/27/2026
• Andrew Kaplowitz from Citigroup set a target price of $265.0 on 01/30/2026
• Deane Dray from RBC Capital set a target price of $268.0 on 01/30/2026
• Stephen Tusa from JP Morgan set a target price of $260.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,870,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/10, 11/18 and 1 sale worth up to $15,000 on 12/19.
• REPRESENTATIVE J. FRENCH HILL sold up to $250,000 on 12/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Hedge Fund Activity

We have seen 1,255 institutional investors add shares of PFE stock to their portfolio, and 1,588 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 101,068,901 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $2,516,615,634
• NORGES BANK removed 20,119,761 shares (-21.5%) from their portfolio in Q4 2025, for an estimated $500,982,048
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 17,862,459 shares (-96.2%) from their portfolio in Q4 2025, for an estimated $444,775,229
• PACER ADVISORS, INC. removed 17,574,851 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $437,613,789
• MORGAN STANLEY added 14,342,946 shares (+19.2%) to their portfolio in Q4 2025, for an estimated $357,139,355
• BANK OF NEW YORK MELLON CORP added 13,581,757 shares (+38.9%) to their portfolio in Q4 2025, for an estimated $338,185,749
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 8,837,922 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $220,064,257

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PFE Analyst Ratings

Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 11/24/2025

To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.

PFE Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 10 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.

Here are some recent targets:

• David Toung from Argus Research set a target price of $35.0 on 03/02/2026
• Trung Huynh from RBC Capital set a target price of $25.0 on 02/25/2026
• Emily Field from Barclays set a target price of $25.0 on 02/20/2026
• Carter Gould from Cantor Fitzgerald set a target price of $27.0 on 02/04/2026
• Michael Yee from UBS set a target price of $25.0 on 01/07/2026
• Terence Flynn from Morgan Stanley set a target price of $27.0 on 12/17/2025
• Jason Gerberry from B of A Securities set a target price of $28.0 on 12/15/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$80,000 of COHERUS BIOSCIENCES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response."

You can find more data on corporate lobbying on Quiver Quantitative.

CHRS Hedge Fund Activity

We have seen 60 institutional investors add shares of CHRS stock to their portfolio, and 59 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• TANG CAPITAL MANAGEMENT LLC removed 2,372,853 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $3,369,451
• MACQUARIE GROUP LTD removed 899,999 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,277,998
• RUBRIC CAPITAL MANAGEMENT LP removed 867,800 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,423,192
• TEJARA CAPITAL LTD removed 698,770 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,145,982
• MILLENNIUM MANAGEMENT LLC added 660,451 shares (+inf%) to their portfolio in Q4 2025, for an estimated $937,840
• GSA CAPITAL PARTNERS LLP added 477,481 shares (+inf%) to their portfolio in Q4 2025, for an estimated $678,023
• TWO SIGMA INVESTMENTS, LP added 468,163 shares (+1310.9%) to their portfolio in Q4 2025, for an estimated $664,791

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of NIOCORP DEVELOPMENTS LTD lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General issues related to critical minerals mining, processing, and security. Critical Minerals Investment Tax Modernization Act (H.R.4772). National Defense Authorization Act for Fiscal Year 2026 (P.L. 119-60). FY2026 Defense Appropriations legislation Critical Minerals Investment Tax Modernization Act (H.R.4772)."

You can find more data on corporate lobbying on Quiver Quantitative.

NB Hedge Fund Activity

We have seen 137 institutional investors add shares of NB stock to their portfolio, and 54 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC removed 7,715,744 shares (-97.5%) from their portfolio in Q4 2025, for an estimated $40,893,443
• BLACKROCK, INC. added 2,729,334 shares (+74.7%) to their portfolio in Q4 2025, for an estimated $14,465,470
• ALYESKA INVESTMENT GROUP, L.P. removed 1,201,102 shares (-42.9%) from their portfolio in Q4 2025, for an estimated $6,365,840
• MARSHALL WACE, LLP removed 1,156,057 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,127,102
• BREVAN HOWARD CAPITAL MANAGEMENT LP added 1,109,874 shares (+76.5%) to their portfolio in Q4 2025, for an estimated $5,882,332
• HITE HEDGE ASSET MANAGEMENT LLC removed 827,701 shares (-56.6%) from their portfolio in Q4 2025, for an estimated $4,386,815
• NUVEEN, LLC added 779,709 shares (+785.0%) to their portfolio in Q4 2025, for an estimated $4,132,457

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NB Analyst Ratings

Wall Street analysts have issued reports on $NB in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• William Blair issued a "Outperform" rating on 10/20/2025
• HC Wainwright & Co. issued a "Buy" rating on 09/22/2025

To track analyst ratings and price targets for NB, check out Quiver Quantitative's $NB forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$220,000 of RIVIAN AUTOMOTIVE LLC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues affecting automotive and automotive supply chain in the US, including consumer tax incentives, commercial tax incentives, and emissions standards. Issues affecting autonomous vehicles, including SELF DRIVE Act Issues affecting manufacturing investment in the US, including the 45X battery investment credit and the Advanced Technology Vehicle Manufacturing program. Tariffs affecting the automotive indutry"

You can find more data on corporate lobbying on Quiver Quantitative.

RIVN Insider Trading Activity

RIVN insiders have traded $RIVN stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $RIVN stock by insiders over the last 6 months:

• ROBERT J SCARINGE (Chief Executive Officer) has made 0 purchases and 10 sales selling 209,400 shares for an estimated $3,508,073.
• CLAIRE MCDONOUGH (Chief Financial Officer) has made 0 purchases and 3 sales selling 56,382 shares for an estimated $963,870.
• PETER KRAWIEC sold 3,655 shares for an estimated $71,076

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RIVN Hedge Fund Activity

We have seen 342 institutional investors add shares of RIVN stock to their portfolio, and 376 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 40,081,320 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $790,002,817
• JPMORGAN CHASE & CO added 16,373,939 shares (+287.6%) to their portfolio in Q4 2025, for an estimated $322,730,337
• D. E. SHAW & CO., INC. added 9,282,134 shares (+212.3%) to their portfolio in Q4 2025, for an estimated $182,950,861
• TWO SIGMA ADVISERS, LP added 6,379,420 shares (+44.7%) to their portfolio in Q4 2025, for an estimated $125,738,368
• JANE STREET GROUP, LLC removed 5,783,322 shares (-80.8%) from their portfolio in Q4 2025, for an estimated $113,989,276
• UBS GROUP AG removed 5,577,143 shares (-28.6%) from their portfolio in Q4 2025, for an estimated $109,925,488
• WORLDQUANT MILLENNIUM ADVISORS LLC removed 4,578,845 shares (-86.7%) from their portfolio in Q4 2025, for an estimated $90,249,034

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RIVN Analyst Ratings

Wall Street analysts have issued reports on $RIVN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Deutsche Bank issued a "Buy" rating on 02/13/2026
• Wolfe Research issued a "Underperform" rating on 01/12/2026
• Baird issued a "Outperform" rating on 12/18/2025
• Stifel issued a "Buy" rating on 11/17/2025
• Tigress Financial issued a "Buy" rating on 11/14/2025
• Mizuho issued a "Underperform" rating on 10/20/2025

To track analyst ratings and price targets for RIVN, check out Quiver Quantitative's $RIVN forecast page.

RIVN Price Targets

Multiple analysts have issued price targets for $RIVN recently. We have seen 17 analysts offer price targets for $RIVN in the last 6 months, with a median target of $18.0.

Here are some recent targets:

• Stephen Gengaro from Stifel set a target price of $20.0 on 02/17/2026
• Michael Shlisky from DA Davidson set a target price of $14.0 on 02/17/2026
• Joseph Spak from UBS set a target price of $16.0 on 02/13/2026
• Colin Langan from Wells Fargo set a target price of $15.0 on 02/13/2026
• Alexander Potter from Piper Sandler set a target price of $18.0 on 02/13/2026
• Dan Ives from Wedbush set a target price of $25.0 on 02/13/2026
• Mickey Legg from Benchmark set a target price of $25.0 on 02/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of ZOOMINFO TECHNOLOGIES LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to consumer privacy legislation, specifically affecting B2B businesses. Issues related to consumer privacy legislation, specifically affecting B2B businesses."

You can find more data on corporate lobbying on Quiver Quantitative.

GTM Insider Trading Activity

GTM insiders have traded $GTM stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $GTM stock by insiders over the last 6 months:

• JAMES M ROTH (Chief Revenue Officer) has made 0 purchases and 4 sales selling 62,986 shares for an estimated $485,611.
• ASHLEY MCGRANE (General Counsel and Corp Sec) has made 0 purchases and 7 sales selling 9,799 shares for an estimated $110,508.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GTM Hedge Fund Activity

We have seen 164 institutional investors add shares of GTM stock to their portfolio, and 231 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MACQUARIE GROUP LTD removed 16,728,210 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $170,125,895
• CONTOUR ASSET MANAGEMENT LLC removed 3,840,173 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,054,559
• PACER ADVISORS, INC. added 3,358,108 shares (+8942.1%) to their portfolio in Q4 2025, for an estimated $34,151,958
• POINT72 ASSET MANAGEMENT, L.P. removed 3,122,271 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $31,753,496
• HOOD RIVER CAPITAL MANAGEMENT LLC removed 2,858,740 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $31,188,853
• LSV ASSET MANAGEMENT added 2,674,753 shares (+35.6%) to their portfolio in Q4 2025, for an estimated $27,202,238
• FMR LLC added 2,604,302 shares (+12.5%) to their portfolio in Q4 2025, for an estimated $26,485,751

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GTM Analyst Ratings

Wall Street analysts have issued reports on $GTM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 02/03/2026
• BTIG issued a "Buy" rating on 12/17/2025
• Goldman Sachs issued a "Sell" rating on 11/04/2025
• RBC Capital issued a "Underperform" rating on 11/04/2025
• Wells Fargo issued a "Underweight" rating on 10/01/2025

To track analyst ratings and price targets for GTM, check out Quiver Quantitative's $GTM forecast page.

GTM Price Targets

Multiple analysts have issued price targets for $GTM recently. We have seen 13 analysts offer price targets for $GTM in the last 6 months, with a median target of $9.0.

Here are some recent targets:

• Clark Wright from DA Davidson set a target price of $7.0 on 02/11/2026
• Tyler Radke from Citigroup set a target price of $6.5 on 02/11/2026
• Raimo Lenschow from Barclays set a target price of $9.0 on 02/11/2026
• Siti Panigrahi from Mizuho set a target price of $10.0 on 02/10/2026
• Elizabeth Porter from Morgan Stanley set a target price of $9.0 on 02/10/2026
• Taylor McGinnis from UBS set a target price of $8.5 on 02/10/2026
• Rishi Jaluria from RBC Capital set a target price of $7.0 on 02/10/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,360,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Implementation and oversight of the Agriculture Marketing Act of 1946 to require the Secretary of Proposed update to plant incorporated protectant rule and proposed update to guidance clarifying the regulatory approach for food from plantsdeveloped with the newest tools of genome editing. 7CFR Part 340 Pesticide Matters Seed Matters Climate change matters 2024 Farm Bill Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Biostimulant regulatory matters Pesticide matters Farm Bill 2024 Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Pesticide matters Climate change matters Trade Intellectual property rights and protection Agriculture trade Trade and international relations Tariff matters Seed trade matters Issues related to Mexico's regulation of agricultural biotechnology and pesticides Corporate taxation matters Taxation matters impacting US farmers 2025 NDAA Intellectual property rights and protection Technology access"

You can find more data on corporate lobbying on Quiver Quantitative.

CTVA Insider Trading Activity

CTVA insiders have traded $CTVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:

• BRIAN TITUS (See Remarks) has made 0 purchases and 2 sales selling 8,311 shares for an estimated $636,199.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CTVA Hedge Fund Activity

We have seen 576 institutional investors add shares of CTVA stock to their portfolio, and 725 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 11,456,910 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $767,956,677
• CAPITAL INTERNATIONAL INVESTORS removed 10,801,587 shares (-92.8%) from their portfolio in Q4 2025, for an estimated $724,030,376
• HARRIS ASSOCIATES L P added 10,675,052 shares (+168.1%) to their portfolio in Q4 2025, for an estimated $715,548,735
• FMR LLC added 5,962,615 shares (+25.8%) to their portfolio in Q4 2025, for an estimated $399,674,083
• JANUS HENDERSON GROUP PLC removed 3,132,619 shares (-29.2%) from their portfolio in Q4 2025, for an estimated $209,979,451
• NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,100,709 shares (+6527.4%) to their portfolio in Q4 2025, for an estimated $207,840,524
• BLACKROCK, INC. added 2,901,736 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $194,503,364

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CTVA Analyst Ratings

Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 10/30/2025
• Wells Fargo issued a "Overweight" rating on 10/16/2025
• Argus Research issued a "Buy" rating on 10/13/2025

To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.

CTVA Price Targets

Multiple analysts have issued price targets for $CTVA recently. We have seen 10 analysts offer price targets for $CTVA in the last 6 months, with a median target of $80.0.

Here are some recent targets:

• John Roberts from Mizuho set a target price of $82.0 on 02/17/2026
• Jeffrey Zekauskas from JP Morgan set a target price of $77.0 on 02/05/2026
• Arun Viswanathan from RBC Capital set a target price of $89.0 on 02/05/2026
• Michael Sison from Wells Fargo set a target price of $85.0 on 02/05/2026
• Patrick Cunningham from Citigroup set a target price of $80.0 on 02/05/2026
• Kristen Owen from Oppenheimer set a target price of $78.0 on 01/27/2026
• Joshua Spector from UBS set a target price of $81.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$380,000 of CHUBB INA HOLDINGS INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Various Issues related to the Federal Insurance Office (FIO) and Federal Advisory Committee on Insurance (FACI). Issues related to international capital standards and covered agreements. Issues related to/impacting cyber insurance coverage, ransomware and incident reporting. Issues related to Privacy legislation. Issues related to various Surety & Fidelity Bond requirements. Issues related to risk mitigation and resiliency. Issues related to insurance coverage for various natural catastophes. Issues related to the National Flood Insurance Program (NFIP). Issues related to cannabis safe harbor for insurers. S. 570 / H.R. 1285 - Water Infrastructure Subcontractor and Taxpayer Protection Act. S. 245 - Insure CyberSecurity Act. Issues related to Artificial Intelligence. H.R.643 - Federal Insurance Office Elimination Act S.1544/H.R.3437 - Insurance Data Protection Act Reauthorization of the Cybersecurity Information Sharing Act of 2015 Issues related to international tax proposals. Issues related to third party litigation funding and lawsuit lending. Issues related to U.S. engagement in OECD tax initiatives. Issues related to TCJA extension & various corporate and insurance related tax provisions. S.1821/H.R.3512 - Tackling Predatory Litigation Funding Act. H.R.1 - One Big Beautiful Bill Act Issues related to Mexico's VAT. Issues related to the implementation and review of the U.S.-Mexico-Canada Agreement. Discussions on China-related legislation. Issues related to digital trade, data flows and Artificial Intelligence. Issues related to Sanctions. Issues related to Investment. Issues related to U.S.-Swiss Tax treaty. Issues related to Malaysia divestment requirement. Issues related to U.S. tariffs and trade negotiations. Various issues related to transparency in asbestos bankruptcy trusts. Various tort reform and liability related issues. Issues surrounding arbitration clauses in contracts. Issues related to third party litigation funding and lawsuit lending. S. 706 / H.R. 1530 - Ensuring Justice for Victims of Terrorism Act. H.R. 2675 - Protecting our Courts from Foreign Manipulation Act of 2025."

You can find more data on corporate lobbying on Quiver Quantitative.

CB Congressional Stock Trading

Members of Congress have traded $CB stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CB Insider Trading Activity

CB insiders have traded $CB stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:

• JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 40,073 shares for an estimated $11,513,506.
• EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 29,985 shares for an estimated $9,993,140.
• TIMOTHY ALAN BOROUGHS (Executive Vice President*) has made 0 purchases and 2 sales selling 11,430 shares for an estimated $3,384,390.
• JOSEPH F WAYLAND (Executive Vice President and*) sold 5,830 shares for an estimated $1,731,976
• GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 5,140 shares for an estimated $1,672,698.
• JUAN LUIS ORTEGA (Executive Vice President*) sold 4,357 shares for an estimated $1,285,489

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CB Hedge Fund Activity

We have seen 950 institutional investors add shares of CB stock to their portfolio, and 923 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 3,049,987 shares (+25.6%) to their portfolio in Q4 2025, for an estimated $951,961,942
• BERKSHIRE HATHAWAY INC added 2,916,288 shares (+9.3%) to their portfolio in Q4 2025, for an estimated $910,231,810
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,548,307 shares (+inf%) to their portfolio in Q4 2025, for an estimated $795,377,580
• GQG PARTNERS LLC added 1,647,729 shares (+15.2%) to their portfolio in Q4 2025, for an estimated $514,289,175
• FMR LLC removed 1,468,730 shares (-11.9%) from their portfolio in Q4 2025, for an estimated $458,420,007
• AQR CAPITAL MANAGEMENT LLC added 1,443,335 shares (+51.6%) to their portfolio in Q4 2025, for an estimated $450,493,720
• VIKING GLOBAL INVESTORS LP added 1,013,839 shares (+inf%) to their portfolio in Q4 2025, for an estimated $316,439,428

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CB Analyst Ratings

Wall Street analysts have issued reports on $CB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 01/08/2026
• Keefe, Bruyette & Woods issued a "Outperform" rating on 01/06/2026
• JMP Securities issued a "Market Outperform" rating on 10/22/2025
• Evercore ISI Group issued a "Outperform" rating on 10/01/2025

To track analyst ratings and price targets for CB, check out Quiver Quantitative's $CB forecast page.

CB Price Targets

Multiple analysts have issued price targets for $CB recently. We have seen 18 analysts offer price targets for $CB in the last 6 months, with a median target of $337.5.

Here are some recent targets:

• Michael Zaremski from BMO Capital set a target price of $326.0 on 02/10/2026
• Matthew Heimermann from Citigroup set a target price of $385.0 on 02/09/2026
• Meyer Shields from Keefe, Bruyette & Woods set a target price of $373.0 on 02/09/2026
• C. Gregory Peters from Raymond James set a target price of $380.0 on 02/09/2026
• Yaron Kinar from Mizuho set a target price of $336.0 on 02/06/2026
• Elyse Greenspan from Wells Fargo set a target price of $322.0 on 02/05/2026
• David Motemaden from Evercore ISI Group set a target price of $347.0 on 02/04/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,170,000 of FEDEX CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.574/S.187 - ALIGN Act Legislative monitoring for tax credits involving EVs, SAFs, and zero emission charging infrastructure. Corporate and international tax issues related to the Tax Cuts and Jobs Act. H.R.1062 - Growing and Preserving Innovation in America Act of 2025. General monitoring of administration policy and Executive Orders. H.R.1 - The One Big Beautiful Bill. H.R. 1177/S. 492-Improve and Enhance the Work Opportunity Tax Credit Act. Legislative monitoring of U.S. Postal Service-related issues. General monitoring of administration policy and Executive Orders. S.1604 - No RTO Act. H.R.3004 - USPS SERVES US Act. S. 986 - STOP Act 2.0. H.R. 3011 - USPS Shipping Equity Act. H.Res.70/S.Res.147 - Expressing the sense of the House of Representatives that Congress should take all appropriate measures to ensure that the United States Postal Service remains an independent establishment of the Federal Government and is not subject to privatization. Legislative monitoring of Open Skies Agreements. Legislative monitoring of general trade issues including customs modernization, GSP, MTB, IPEF, CBAM, and de minimis. Legislative monitoring around China PNTR. Foreign Pollution Fee Act of 2025. S.1259 - Manifest Modernization Act of 2025. H.R.1840 - Closing the De Minimis Loophole Act. H.R.805 - End Chinas De Minimis Abuse Act. H.R.322 - Import Security and Fairness Act. H.R.1504 - China Trade Relations Act of 2025. H.R.694 - Restoring Trade Fairness Act. S.206 - Restoring Trade Fairness Act. H.R.407 - Prevent Tariff Abuse Act. S.956 - Customs Facilitation Act of 2025. H.R.1 - The One Big Beautiful Bill. General monitoring of administration policy and Executive Orders. H.Con.Res.14 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 . FY 2026 Transportation, Housing, and Urban Development, and Related Agencies Appropriations bills. FY 2026 Homeland Security (DHS) Appropriations General monitoring of administration policy and Executive Orders. Legislative monitoring on aviation security and aviation safety issues including all-cargo flight time and duty rules; ATC modernization; and Open Skies agreements. General monitoring of administration policy and Executive Orders. S.1985 - Safe Operations of Shared Airspace Act of 2025. S.1706 - A bill to require aircraft operating in Class B airspace in the national airspace system to install and operate ADS-B In and ADS-B Out equipment, and for other purposes. S.2503 - Rotorcraft Operations Transparency and Oversight Reform Act. Transporation Security Reauthorization Act. H.R.2424 - Modern, Clean, and Safe Trucks Act of 2025. H.R.2391 - Strengthening the Supply Chain Through Truck Drivers Incentives Act of 2025. H.R.1659 - Truck Parking Safety Improvement Act. H.R.2514 - Trucker Bathroom Access Act. H.R. 2954/S. 1537 - Veterans Transition to Trucking Act of 2025. S.711 - Transportation Freedom Act. General monitoring of the DOT English Language Proficiency Rule. Legislative monitoring of AV bills, including vehicle data ownership and zero occupant vehicles. General monitoring of administration policy and Executive Orders. Surface Transportation Reauthorization Draft. H.R.3373 - GHOST Act. S.345/H.R.850 - Silencers Help Us Save Hearing (SHUSH) Act. General monitoring of legislation related to shipping restricted commodities. H.R.20/S.852 - Richard L. Trumka Protecting the Right to Organize Act of 2025. H.R.1962/S.893 - Guaranteeing Overtime For Truckers Act. H.R. 4366 - Save Local Business Act. H.R. 5267 - American Franchise Act. S.844 - Faster Labor Contracts Act. S. 2163 - Warehouse Worker Protection Act. DOL Independent Contractor Rule. NLRB Joint Employer Rule. Package Delivery Parity Act Discussion Draft. Legislative monitoring of activity related to the Railway Labor Act (RLA). General monitoring of the OSHA Walkaround Rule. General monitoring of the OSHA Heat Illness Rule. General monitoring of administration policy and Executive Orders. Legislative monitoring of H1b visas and critical worker immigration. General monitoring of administration policy and Executive Orders. Legislative monitoring of consumer privacy issues, vehicle data issues, and AI. H.R.1566 - REPAIR Act. H.R.1664/S.1492 - Deploying American Blockchains Act of 2025. General monitoring of administration policy and Executive Orders. Legislative monitoring of federal contracting issues. General monitoring of administration policy and Executive Orders. S.382/H.R.925 - Dismantle DEI Act S. 2296, the National Defense Authorization Act for FY 2026"

You can find more data on corporate lobbying on Quiver Quantitative.

FDX Congressional Stock Trading

Members of Congress have traded $FDX stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $FDX stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

FDX Hedge Fund Activity

We have seen 822 institutional investors add shares of FDX stock to their portfolio, and 871 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,071,468 shares (-75.3%) from their portfolio in Q4 2025, for an estimated $1,176,084,246
• FMR LLC added 2,053,626 shares (+69.5%) to their portfolio in Q4 2025, for an estimated $593,210,406
• PRIMECAP MANAGEMENT CO/CA/ removed 929,579 shares (-9.8%) from their portfolio in Q4 2025, for an estimated $268,518,189
• BALYASNY ASSET MANAGEMENT L.P. added 745,703 shares (+27008.4%) to their portfolio in Q4 2025, for an estimated $215,403,768
• WADDELL & ASSOCIATES, LLC added 738,122 shares (+164.0%) to their portfolio in Q4 2025, for an estimated $213,213,920
• CAPITAL INTERNATIONAL INVESTORS removed 685,766 shares (-15.9%) from their portfolio in Q4 2025, for an estimated $198,090,366
• DODGE & COX removed 642,992 shares (-4.0%) from their portfolio in Q4 2025, for an estimated $185,734,669

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

FDX Analyst Ratings

Wall Street analysts have issued reports on $FDX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Stifel issued a "Buy" rating on 12/19/2025
• Morgan Stanley issued a "Underweight" rating on 12/19/2025
• Truist Securities issued a "Buy" rating on 12/19/2025
• Stephens & Co. issued a "Overweight" rating on 12/19/2025
• Citigroup issued a "Buy" rating on 12/19/2025
• Jefferies issued a "Buy" rating on 12/19/2025

To track analyst ratings and price targets for FDX, check out Quiver Quantitative's $FDX forecast page.

FDX Price Targets

Multiple analysts have issued price targets for $FDX recently. We have seen 18 analysts offer price targets for $FDX in the last 6 months, with a median target of $337.5.

Here are some recent targets:

• Jonathan Chappell from Evercore ISI Group set a target price of $380.0 on 02/24/2026
• Fadi Chamoun from BMO Capital set a target price of $400.0 on 02/13/2026
• Jason H. Seidl from TD Cowen set a target price of $383.0 on 02/13/2026
• Christian Wetherbee from Wells Fargo set a target price of $430.0 on 02/13/2026
• Reed Seay from Stephens & Co. set a target price of $405.0 on 02/13/2026
• Brandon Oglenski from Barclays set a target price of $450.0 on 02/10/2026
• Ariel Rosa from Citigroup set a target price of $401.0 on 02/05/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of INVIVYD INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

IVVD Insider Trading Activity

IVVD insiders have traded $IVVD stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $IVVD stock by insiders over the last 6 months:

• KEVIN F MCLAUGHLIN purchased 50,000 shares for an estimated $125,000
• JILL ANDERSEN (Chief Legal Officer, Secretary) has made 0 purchases and 2 sales selling 67,710 shares for an estimated $105,580.
• WILLIAM E. DUKE (Chief Financial Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
• JULIE GREEN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
• TIMOTHY EDWARD LEE (Chief Commercial Officer) has made 0 purchases and 2 sales selling 40,627 shares for an estimated $63,350.
• ROBERT D. III ALLEN (Chief Scientific Officer) has made 0 purchases and 2 sales selling 37,581 shares for an estimated $58,600.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IVVD Hedge Fund Activity

We have seen 72 institutional investors add shares of IVVD stock to their portfolio, and 40 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PERCEPTIVE ADVISORS LLC added 21,785,166 shares (+inf%) to their portfolio in Q4 2025, for an estimated $53,809,360
• BVF INC/IL added 19,525,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $48,226,750
• DEEP TRACK CAPITAL, LP removed 8,585,980 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,444,578
• SATURN V CAPITAL MANAGEMENT LP added 7,735,386 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,106,403
• SOLEUS CAPITAL MANAGEMENT, L.P. added 7,708,727 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,040,555
• JANUS HENDERSON GROUP PLC added 7,160,065 shares (+28.2%) to their portfolio in Q4 2025, for an estimated $17,685,360
• EVENTIDE ASSET MANAGEMENT, LLC added 5,809,256 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,348,862

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

IVVD Analyst Ratings

Wall Street analysts have issued reports on $IVVD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 12/23/2025
• HC Wainwright & Co. issued a "Buy" rating on 11/03/2025
• Cantor Fitzgerald issued a "Overweight" rating on 10/06/2025

To track analyst ratings and price targets for IVVD, check out Quiver Quantitative's $IVVD forecast page.

IVVD Price Targets

Multiple analysts have issued price targets for $IVVD recently. We have seen 4 analysts offer price targets for $IVVD in the last 6 months, with a median target of $10.0.

Here are some recent targets:

• Thomas Shrader from BTIG set a target price of $10.0 on 12/23/2025
• Patrick R. Trucchio from HC Wainwright & Co. set a target price of $10.0 on 11/03/2025
• Josh Schimmer from Cantor Fitzgerald set a target price of $10.0 on 10/06/2025
• Jason Kolbert from D. Boral Capital set a target price of $2.0 on 10/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$50,000 of INTUIT INC. AND AFFILIATES lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to AI and innovation to benefit consumers and small businesses Issues related to supporting greater access to financial services and financial inclusion; Promoting payments infrastructure modernization and market competition"

You can find more data on corporate lobbying on Quiver Quantitative.

INTU Congressional Stock Trading

Members of Congress have traded $INTU stock 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $INTU stock by members of Congress over the last 6 months:

• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 2 purchases worth up to $100,000 on 12/29, 09/24 and 0 sales.
• REPRESENTATIVE JULIA LETLOW purchased up to $15,000 on 10/01.
• REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
• SENATOR JOHN W. HICKENLOOPER purchased up to $250,000 on 09/02.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

INTU Insider Trading Activity

INTU insiders have traded $INTU stock on the open market 118 times in the past 6 months. Of those trades, 0 have been purchases and 118 have been sales.

Here’s a breakdown of recent trading of $INTU stock by insiders over the last 6 months:

• SCOTT D COOK has made 0 purchases and 100 sales selling 494,894 shares for an estimated $327,893,677.
• SASAN K GOODARZI (CEO, President and Director) has made 0 purchases and 2 sales selling 41,000 shares for an estimated $26,653,960.
• SANDEEP AUJLA (EVP and CFO) has made 0 purchases and 5 sales selling 3,644 shares for an estimated $2,401,358.
• RICHARD L DALZELL has made 0 purchases and 11 sales selling 1,998 shares for an estimated $1,321,068.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

INTU Hedge Fund Activity

We have seen 1,068 institutional investors add shares of INTU stock to their portfolio, and 1,122 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 10,202,831 shares (-76.4%) from their portfolio in Q4 2025, for an estimated $6,758,559,311
• JPMORGAN CHASE & CO added 1,139,677 shares (+10.8%) to their portfolio in Q4 2025, for an estimated $754,944,838
• PARNASSUS INVESTMENTS, LLC removed 1,134,238 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $774,582,472
• BLACKROCK, INC. removed 1,073,713 shares (-3.9%) from their portfolio in Q4 2025, for an estimated $711,248,965
• COATUE MANAGEMENT LLC removed 839,460 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $556,075,093
• AMUNDI removed 782,984 shares (-42.1%) from their portfolio in Q4 2025, for an estimated $518,664,261
• LONE PINE CAPITAL LLC removed 771,666 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $526,978,428

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

INTU Analyst Ratings

Wall Street analysts have issued reports on $INTU in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 01/08/2026
• BMO Capital issued a "Outperform" rating on 11/21/2025
• Wells Fargo issued a "Overweight" rating on 11/21/2025
• RBC Capital issued a "Outperform" rating on 11/21/2025
• Evercore ISI Group issued a "Outperform" rating on 11/18/2025

To track analyst ratings and price targets for INTU, check out Quiver Quantitative's $INTU forecast page.

INTU Price Targets

Multiple analysts have issued price targets for $INTU recently. We have seen 7 analysts offer price targets for $INTU in the last 6 months, with a median target of $700.0.

Here are some recent targets:

• Daniel Jester from BMO Capital set a target price of $624.0 on 02/10/2026
• Jared Levine from TD Cowen set a target price of $658.0 on 02/09/2026
• Scott Schneeberger from Oppenheimer set a target price of $696.0 on 02/03/2026
• Michael Turrin from Wells Fargo set a target price of $700.0 on 01/08/2026
• Arvind Ramnani from Truist Securities set a target price of $739.0 on 01/06/2026
• Rishi Jaluria from RBC Capital set a target price of $850.0 on 11/21/2025
• Kirk Materne from Evercore ISI Group set a target price of $875.0 on 11/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of AEMETIS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Section 45Z extension Section 45Z production tax credit"

You can find more data on corporate lobbying on Quiver Quantitative.

AMTX Hedge Fund Activity

We have seen 31 institutional investors add shares of AMTX stock to their portfolio, and 47 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VANGUARD GROUP INC added 455,837 shares (+18.4%) to their portfolio in Q4 2025, for an estimated $633,613
• MARSHALL WACE, LLP added 415,978 shares (+289.3%) to their portfolio in Q4 2025, for an estimated $578,209
• MILLENNIUM MANAGEMENT LLC removed 411,723 shares (-77.7%) from their portfolio in Q4 2025, for an estimated $572,294
• RENAISSANCE TECHNOLOGIES LLC removed 363,001 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $504,571
• GOLDMAN SACHS GROUP INC removed 334,894 shares (-77.6%) from their portfolio in Q4 2025, for an estimated $465,502
• 683 CAPITAL MANAGEMENT, LLC added 235,557 shares (+inf%) to their portfolio in Q4 2025, for an estimated $327,424
• HAMILTON CAPITAL PARTNERS, LLC added 200,686 shares (+inf%) to their portfolio in Q4 2025, for an estimated $278,953

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMTX Analyst Ratings

Wall Street analysts have issued reports on $AMTX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Ascendiant Capital issued a "Buy" rating on 11/19/2025

To track analyst ratings and price targets for AMTX, check out Quiver Quantitative's $AMTX forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,490,000 of UNITED AIRLINES INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Customer-related issues. Air Traffic Control Reform, Staffing, and Modernization. Government Shutdown Impacts on Federal Aviation Administration. DOT and FAA Regulations. S. 1045/H.R. 5455, Aviation Funding Stability Act, to provide funding for the FAA in the event of a lapse in appropriations. H.R. 6086, Aviation Funding Solvency Act, to provide funding for the FAA in the event of a lapse in appropriations. S. 697, Air Traffic Control Workforce Development Act of 2025, all provisions. S. 1985, Safe Operations of Shared Airspace Act of 2025, most provisions. H.R. 3530, Flight Education Access Act, all provisions. H.R. 2591/S. 3257, Mental Health in Aviation Act of 2025, all provisions. H.R. 2592, Aviation Medication Transparency Act of 2025, all provisions. P.L. 118-63, FAA Reauthorization Act of 2024, most provisions. Credit Card Competition Act (no current bill number). H.R. 1719/S. 144, Farm to Fly Act of 2025, all provisions. S. 1422, Fanner First Fuel Incentives Act, provisions related to aviation. S. 2503, ROTOR Act, all provisions. H.R. 6518, SAF Act, all provisions. Issues pertaining to security screening and biometric technology. Issues pertaining to cabotage regulations. Issues pertaining to airline frequent flyer programs. Issues pertaining to airline workforce and labor. Issues pertaining to FCC spectrum auction/aircraft radio altimeter interference. Issues pertaining to Department of State Travel Advisory Requirements. Budget Reconciliation - Air Traffic Controller Staffing. Budget and appropriations related to the airline industry for Fiscal Year 2025 and Fiscal Year 2026. Issues pertaining to Aviation taxes and fees. Issues pertaining to Sustainable Aviation Fuels. Issues pertaining to Sustainable Aviation Fuels."

You can find more data on corporate lobbying on Quiver Quantitative.

UAL Congressional Stock Trading

Members of Congress have traded $UAL stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $UAL stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 12/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UAL Insider Trading Activity

UAL insiders have traded $UAL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $UAL stock by insiders over the last 6 months:

• J SCOTT KIRBY (Chief Executive Officer) sold 120,000 shares for an estimated $12,943,800
• BRETT J HART (President) sold 19,000 shares for an estimated $2,022,568

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UAL Hedge Fund Activity

We have seen 545 institutional investors add shares of UAL stock to their portfolio, and 446 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITADEL ADVISORS LLC added 4,010,216 shares (+1218.4%) to their portfolio in Q3 2025, for an estimated $386,985,844
• CAPITAL INTERNATIONAL INVESTORS removed 3,815,497 shares (-17.3%) from their portfolio in Q4 2025, for an estimated $426,648,874
• BALYASNY ASSET MANAGEMENT L.P. added 2,646,053 shares (+inf%) to their portfolio in Q3 2025, for an estimated $255,344,114
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,048,224 shares (-72.5%) from their portfolio in Q4 2025, for an estimated $229,032,407
• PRIMECAP MANAGEMENT CO/CA/ removed 2,024,470 shares (-11.2%) from their portfolio in Q4 2025, for an estimated $226,376,235
• FMR LLC added 1,857,987 shares (+12.8%) to their portfolio in Q4 2025, for an estimated $207,760,106
• TWO SIGMA INVESTMENTS, LP added 1,305,748 shares (+3647.3%) to their portfolio in Q4 2025, for an estimated $146,008,741

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UAL Analyst Ratings

Wall Street analysts have issued reports on $UAL in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Cowen issued a "Buy" rating on 01/22/2026
• Barclays issued a "Overweight" rating on 01/12/2026
• UBS issued a "Buy" rating on 01/06/2026
• Wells Fargo issued a "Overweight" rating on 12/18/2025
• BMO Capital issued a "Outperform" rating on 12/09/2025
• Susquehanna issued a "Positive" rating on 10/03/2025
• Jefferies issued a "Buy" rating on 10/01/2025

To track analyst ratings and price targets for UAL, check out Quiver Quantitative's $UAL forecast page.

UAL Price Targets

Multiple analysts have issued price targets for $UAL recently. We have seen 14 analysts offer price targets for $UAL in the last 6 months, with a median target of $137.5.

Here are some recent targets:

• Atul Maheswari from UBS set a target price of $147.0 on 01/22/2026
• Tom Fitzgerald from TD Cowen set a target price of $140.0 on 01/22/2026
• John Staszak from Argus Research set a target price of $135.0 on 01/22/2026
• Catherine O'Brien from Goldman Sachs set a target price of $129.0 on 01/13/2026
• Brandon Oglenski from Barclays set a target price of $150.0 on 01/12/2026
• Christopher Stathoulopoulos from Susquehanna set a target price of $150.0 on 01/09/2026
• John Godyn from Citigroup set a target price of $153.0 on 01/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of NEWSMAX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Matters relating to TV broadcasting."

You can find more data on corporate lobbying on Quiver Quantitative.

NMAX Hedge Fund Activity

We have seen 85 institutional investors add shares of NMAX stock to their portfolio, and 71 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GREENWICH WEALTH MANAGEMENT LLC added 22,795,352 shares (+inf%) to their portfolio in Q4 2025, for an estimated $176,208,070
• BLACKROCK, INC. added 1,906,588 shares (+353.0%) to their portfolio in Q4 2025, for an estimated $14,737,925
• STATE STREET CORP added 527,126 shares (+520.9%) to their portfolio in Q4 2025, for an estimated $4,074,683
• GEODE CAPITAL MANAGEMENT, LLC added 440,577 shares (+329.1%) to their portfolio in Q4 2025, for an estimated $3,405,660
• GOLDMAN SACHS GROUP INC added 418,199 shares (+1033.1%) to their portfolio in Q4 2025, for an estimated $3,232,678
• UBS GROUP AG added 412,173 shares (+4495.3%) to their portfolio in Q4 2025, for an estimated $3,186,097
• SOVIERO ASSET MANAGEMENT, LP removed 235,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,816,550

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of CLOVER HEALTH lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Medicare Advantage Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

CLOV Insider Trading Activity

CLOV insiders have traded $CLOV stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:

• JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 7 sales selling 65,437 shares for an estimated $203,718.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CLOV Hedge Fund Activity

We have seen 86 institutional investors add shares of CLOV stock to their portfolio, and 109 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BANK OF AMERICA CORP /DE/ removed 3,879,613 shares (-96.7%) from their portfolio in Q3 2025, for an estimated $11,871,615
• MARSHALL WACE, LLP removed 3,523,047 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $10,780,523
• RENAISSANCE TECHNOLOGIES LLC removed 3,221,559 shares (-41.8%) from their portfolio in Q4 2025, for an estimated $7,570,663
• DIVISADERO STREET CAPITAL MANAGEMENT, LP added 2,768,088 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,470,349
• CITADEL ADVISORS LLC removed 2,042,721 shares (-57.9%) from their portfolio in Q3 2025, for an estimated $6,250,726
• BLACKROCK, INC. added 1,885,917 shares (+6.2%) to their portfolio in Q4 2025, for an estimated $4,431,904
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,878,719 shares (-70.7%) from their portfolio in Q4 2025, for an estimated $4,414,989

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CLOV Analyst Ratings

Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Canaccord Genuity issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for CLOV, check out Quiver Quantitative's $CLOV forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,840,000 of APPLE INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Providing information related to Apples efforts around financial services Issues related to open banking and financial technology General tax issues, including expiring tax provisions Providing information regarding Apple's tax posture Issues related to health-related tax provisions Issues related to encryption and cybersecurity, including operation of the CLOUD Act General patent policy, including issues related to the Patent Trial and Appeal Board, S. 1553/H.R. 3160 the PREVAIL Act, and S. 708/H.R. 1574 the RESTORE Patent Rights Act Issues related to standard essential patents Issues related to anti-counterfeit policy General trademark and copyright policy Issues related to patent proceedings and the International Trade Commission, including the Advancing Americas Interests Act General overview of music licensing legal framework Providing general information about Apple's coding and education programs Providing information on Apples commitment to the environment, including recycling efforts Issues related to environmental policy, including critical minerals and renewable energy Issues related to the U.S. - EU Privacy Shield Issues related to anti-counterfeit and anti-piracy policy Issues related to the trade impacts of intellectual property disputes Issues related to U.S. competitiveness in global markets Issues related to tariff and non-tariff trade barriers General consumer privacy issues Providing information relevant to online child safety, including potential legislation, regulatory policy, H.R. 3149/S. 1586 the App Store Accountability Act, H.R. 6333 the Parents Over Platforms Act, and S. 1748 the Kids Online Safety Act Encouraging the development and adoption of strong consumer data privacy protections via legislation and/or regulatory policy Providing information on App Store policies and procedures Providing information related to Apple product features and functionality Issues related to privacy and security practices in the app ecosystem Providing information related to Apple's artificial intelligence offerings including consumer protections Providing information related to the health features of Apples products Providing information related to consumer wearable devices and H.R. 4203 the WEAR IT Act Issues related to competition in digital markets and the app marketplace, including privacy, security, and competitiveness issues related to the American Innovation and Choice Online Act (pre-introduction), S. 2153 the Open App Markets Act, and H.R. 3209 the App Store Freedom Act Educating policymakers about Apples employee base in their states Providing information to policymakers about global regulations impacting competition in digital markets Issues related to immigration reform Issues related to the domestic manufacturing of semiconductors Providing information related to Apples supply chain Providing information related to artificial intelligence and domestic manufacturing Issues related to general spectrum management and policy, including issues related to ultra-wideband uses Issues related to telecommunications and accessibility"

You can find more data on corporate lobbying on Quiver Quantitative.

AAPL Congressional Stock Trading

Members of Congress have traded $AAPL stock 32 times in the past 6 months. Of those trades, 15 have been purchases and 17 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 2 purchases worth up to $30,000 on 01/16 and 2 sales worth up to $30,000 on 10/30.
• SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/15, 12/17 and 0 sales.
• REPRESENTATIVE NANCY PELOSI has traded it 3 times. They made 0 purchases and 3 sales worth up to $50,250,000 on 12/30, 12/24, 10/22.
• SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
• SENATOR TOMMY TUBERVILLE has traded it 2 times. They made 0 purchases and 2 sales worth up to $150,000 on 12/17, 10/07.
• SENATOR SHELLEY MOORE CAPITO has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 12/16, 09/18.
• REPRESENTATIVE DEBBIE DINGELL sold up to $100,000 on 11/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
• REPRESENTATIVE CLEO FIELDS has traded it 5 times. They made 5 purchases worth up to $1,115,000 on 11/13, 10/30, 10/23, 09/10, 09/03 and 0 sales.
• SENATOR KATIE BOYD BRITT sold up to $15,000 on 11/07.
• REPRESENTATIVE RICHARD MCCORMICK purchased up to $15,000 on 11/05.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 5 times. They made 2 purchases worth up to $65,000 on 10/30, 09/11 and 3 sales worth up to $115,000 on 10/31, 10/30, 10/14.
• REPRESENTATIVE VAL T. HOYLE sold up to $50,000 on 09/23.
• SENATOR ADAM B. SCHIFF sold up to $50,000 on 09/22.
• SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 09/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AAPL Insider Trading Activity

AAPL insiders have traded $AAPL stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.

Here’s a breakdown of recent trading of $AAPL stock by insiders over the last 6 months:

• TIMOTHY D COOK (Chief Executive Officer) has made 0 purchases and 4 sales selling 129,963 shares for an estimated $33,375,723.
• ARTHUR D LEVINSON sold 90,000 shares for an estimated $20,886,300
• KATHERINE L. ADAMS (SVP, GC and Secretary) has made 0 purchases and 4 sales selling 47,125 shares for an estimated $12,101,153.
• DEIRDRE O'BRIEN (Senior Vice President) has made 0 purchases and 2 sales selling 43,013 shares for an estimated $11,071,078.
• KEVAN PAREKH (Senior Vice President, CFO) has made 0 purchases and 4 sales selling 4,199 shares for an estimated $1,038,787.
• CHRIS KONDO (Principal Accounting Officer) sold 3,752 shares for an estimated $1,017,654

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AAPL Hedge Fund Activity

We have seen 2,253 institutional investors add shares of AAPL stock to their portfolio, and 3,105 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 315,640,616 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $85,810,057,865
• BERKSHIRE HATHAWAY INC removed 41,787,236 shares (-14.9%) from their portfolio in Q3 2025, for an estimated $10,640,283,902
• CARDANO RISK MANAGEMENT B.V. added 37,746,784 shares (+890.7%) to their portfolio in Q4 2025, for an estimated $10,261,840,698
• VANGUARD GROUP INC added 26,856,752 shares (+1.9%) to their portfolio in Q4 2025, for an estimated $7,301,276,598
• CAPITAL INTERNATIONAL INVESTORS added 15,780,633 shares (+28.2%) to their portfolio in Q4 2025, for an estimated $4,290,122,887
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 11,765,880 shares (+155.5%) to their portfolio in Q3 2025, for an estimated $2,995,946,024
• AXXCESS WEALTH MANAGEMENT, LLC added 11,253,173 shares (+2039.5%) to their portfolio in Q4 2025, for an estimated $3,059,287,611

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AAPL Analyst Ratings

Wall Street analysts have issued reports on $AAPL in the last several months. We have seen 17 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Underweight" rating on 01/30/2026
• JP Morgan issued a "Overweight" rating on 01/30/2026
• Maxim Group issued a "Buy" rating on 01/30/2026
• Wedbush issued a "Outperform" rating on 01/30/2026
• Citigroup issued a "Buy" rating on 01/20/2026
• Evercore ISI Group issued a "Outperform" rating on 01/20/2026
• Morgan Stanley issued a "Overweight" rating on 12/17/2025

To track analyst ratings and price targets for AAPL, check out Quiver Quantitative's $AAPL forecast page.

AAPL Price Targets

Multiple analysts have issued price targets for $AAPL recently. We have seen 27 analysts offer price targets for $AAPL in the last 6 months, with a median target of $310.0.

Here are some recent targets:

• Tom Forte from Maxim Group set a target price of $300.0 on 01/30/2026
• Tim Long from Barclays set a target price of $239.0 on 01/30/2026
• Barton Crockett from Rosenblatt set a target price of $267.0 on 01/30/2026
• Samik Chatterjee from JP Morgan set a target price of $325.0 on 01/30/2026
• Edison Lee from Jefferies set a target price of $286.54 on 01/30/2026
• Dan Ives from Wedbush set a target price of $350.0 on 01/30/2026
• Gil Luria from DA Davidson set a target price of $270.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of NEWSMAX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Matters relating to TV broadcasting."

You can find more data on corporate lobbying on Quiver Quantitative.

NMAX Hedge Fund Activity

We have seen 84 institutional investors add shares of NMAX stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• GREENWICH WEALTH MANAGEMENT LLC added 22,795,352 shares (+inf%) to their portfolio in Q4 2025, for an estimated $176,208,070
• BLACKROCK, INC. added 1,906,588 shares (+353.0%) to their portfolio in Q4 2025, for an estimated $14,737,925
• STATE STREET CORP added 527,126 shares (+520.9%) to their portfolio in Q4 2025, for an estimated $4,074,683
• GEODE CAPITAL MANAGEMENT, LLC added 440,577 shares (+329.1%) to their portfolio in Q4 2025, for an estimated $3,405,660
• GOLDMAN SACHS GROUP INC added 418,199 shares (+1033.1%) to their portfolio in Q4 2025, for an estimated $3,232,678
• UBS GROUP AG added 412,173 shares (+4495.3%) to their portfolio in Q4 2025, for an estimated $3,186,097
• SOVIERO ASSET MANAGEMENT, LP added 235,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $2,914,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NMAX Analyst Ratings

Wall Street analysts have issued reports on $NMAX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Noble Capital Markets issued a "Outperform" rating on 08/21/2025

To track analyst ratings and price targets for NMAX, check out Quiver Quantitative's $NMAX forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of AXOGEN CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"issues related to development of medical products"

You can find more data on corporate lobbying on Quiver Quantitative.

AXGN Insider Trading Activity

AXGN insiders have traded $AXGN stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.

Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:

• WILLIAM P. MR. BURKE has made 0 purchases and 13 sales selling 132,463 shares for an estimated $2,821,444.
• MICHAEL D DALE (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,463 shares for an estimated $2,668,137.
• JOHN JOHNSON has made 0 purchases and 4 sales selling 45,379 shares for an estimated $1,390,392.
• KATHY JOHNSON WEILER has made 0 purchases and 3 sales selling 46,653 shares for an estimated $1,378,475.
• AMY MCBRIDE WENDELL has made 0 purchases and 3 sales selling 43,684 shares for an estimated $1,280,465.
• LINDSEY MARIE HARTLEY (CFO) has made 0 purchases and 3 sales selling 29,199 shares for an estimated $896,298.
• JOSEPH A. TYNDALL has made 0 purchases and 2 sales selling 25,108 shares for an estimated $777,770.
• MARC A BEGAN (EVP & General Counsel) has made 0 purchases and 2 sales selling 22,500 shares for an estimated $686,207.
• PAUL THOMAS sold 21,399 shares for an estimated $633,709
• ERICK WAYNE DEVINNEY (Chief Innovation Officer) has made 0 purchases and 2 sales selling 20,654 shares for an estimated $627,608.
• JENS KEMP (Chief Marketing Officer) sold 8,156 shares for an estimated $254,532

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AXGN Hedge Fund Activity

We have seen 115 institutional investors add shares of AXGN stock to their portfolio, and 92 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST LIGHT ASSET MANAGEMENT, LLC added 1,276,487 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $22,772,528
• WASATCH ADVISORS LP removed 715,779 shares (-43.7%) from their portfolio in Q4 2025, for an estimated $23,427,446
• BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
• BALYASNY ASSET MANAGEMENT L.P. removed 551,516 shares (-28.6%) from their portfolio in Q3 2025, for an estimated $9,839,045
• QUBE RESEARCH & TECHNOLOGIES LTD removed 545,153 shares (-74.8%) from their portfolio in Q3 2025, for an estimated $9,725,529
• SOLEUS CAPITAL MANAGEMENT, L.P. removed 519,698 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $17,009,715
• MARSHALL WACE, LLP removed 454,126 shares (-70.8%) from their portfolio in Q3 2025, for an estimated $8,101,607

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXGN Analyst Ratings

Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
• Mizuho issued a "Outperform" rating on 12/01/2025
• Canaccord Genuity issued a "Buy" rating on 10/30/2025
• Citizens issued a "Market Outperform" rating on 10/30/2025
• Raymond James issued a "Outperform" rating on 10/30/2025

To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.

AXGN Price Targets

Multiple analysts have issued price targets for $AXGN recently. We have seen 7 analysts offer price targets for $AXGN in the last 6 months, with a median target of $37.0.

Here are some recent targets:

• Caitlin Cronin from Canaccord Genuity set a target price of $37.0 on 12/05/2025
• Yi Chen from HC Wainwright & Co. set a target price of $39.0 on 12/05/2025
• Frank Takkinen from Lake Street set a target price of $40.0 on 12/04/2025
• Michael Sarcone from Jefferies set a target price of $36.0 on 12/04/2025
• Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
• David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
• Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$180,000 of SHOPIFY INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to the growth of independent small businesses in the digital economy. Issues related to online government resources for small businesses, including support for the One Stop Shop for Small Business Licensing Act. Issues related to modernizing small business grants and mentoring to promote a greater focus on e-commerce. Issues related to combating online sale of counterfeit goods. Issues related to consumer privacy. Issues related to the reform of laws relating to the protection of intellectual property rights. Issues related to competition in the market for credit card routing, including support for The Credit Card Competition Act. Issues related to Self-Employment Assistance programs and removing barriers to entrepreneurship in unemployment insurance, including support for The NO BOSS Act. Issues related to accessibility standards for website design. Issues related to artificial intelligence and its benefits for small business. Issues related to the regulation of financial technology. Issues related to small business and corporate tax reform. Issues related to the impact of tariffs and changes to the de minimis exemption on small businesses."

You can find more data on corporate lobbying on Quiver Quantitative.

SHOP Congressional Stock Trading

Members of Congress have traded $SHOP stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SHOP stock by members of Congress over the last 6 months:

• REPRESENTATIVE JONATHAN L. JACKSON has traded it 3 times. They made 3 purchases worth up to $165,000 on 12/08, 10/08, 10/06 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SHOP Hedge Fund Activity

We have seen 824 institutional investors add shares of SHOP stock to their portfolio, and 805 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 7,594,495 shares (-79.8%) from their portfolio in Q4 2025, for an estimated $1,222,485,860
• WCM INVESTMENT MANAGEMENT, LLC added 6,700,679 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,078,608,298
• CAPITAL WORLD INVESTORS removed 5,789,891 shares (-10.8%) from their portfolio in Q4 2025, for an estimated $931,998,754
• PRICE T ROWE ASSOCIATES INC /MD/ removed 5,240,796 shares (-16.5%) from their portfolio in Q3 2025, for an estimated $778,834,693
• BAILLIE GIFFORD & CO removed 4,237,555 shares (-12.0%) from their portfolio in Q4 2025, for an estimated $682,119,228
• POLEN CAPITAL MANAGEMENT LLC removed 3,859,034 shares (-34.9%) from their portfolio in Q4 2025, for an estimated $621,188,702
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 3,584,441 shares (-30.1%) from their portfolio in Q3 2025, for an estimated $532,683,777

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SHOP Analyst Ratings

Wall Street analysts have issued reports on $SHOP in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 02/12/2026
• Needham issued a "Buy" rating on 02/12/2026
• Scotiabank issued a "Sector Outperform" rating on 01/08/2026
• Morgan Stanley issued a "Overweight" rating on 11/05/2025
• BMO Capital issued a "Outperform" rating on 11/05/2025
• JP Morgan issued a "Overweight" rating on 11/05/2025
• CIBC issued a "Outperformer" rating on 11/05/2025

To track analyst ratings and price targets for SHOP, check out Quiver Quantitative's $SHOP forecast page.

SHOP Price Targets

Multiple analysts have issued price targets for $SHOP recently. We have seen 23 analysts offer price targets for $SHOP in the last 6 months, with a median target of $170.0.

Here are some recent targets:

• Thanos Moschopoulos from BMO Capital set a target price of $160.0 on 02/12/2026
• Trevor Young from Barclays set a target price of $130.0 on 02/12/2026
• Andrew Boone from Citizens set a target price of $160.0 on 02/12/2026
• Terry Tillman from Truist Securities set a target price of $110.0 on 02/12/2026
• Timothy Chiodo from UBS set a target price of $145.0 on 02/12/2026
• Scott Berg from Needham set a target price of $180.0 on 02/12/2026
• Paul Treiber from RBC Capital set a target price of $170.0 on 02/12/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$70,000 of COEUR MINING INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"mining, federal lands issues"

You can find more data on corporate lobbying on Quiver Quantitative.

CDE Insider Trading Activity

CDE insiders have traded $CDE stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CDE stock by insiders over the last 6 months:

• MITCHELL J KREBS (Chairman, President and CEO) has made 0 purchases and 2 sales selling 250,000 shares for an estimated $3,651,250.
• CASEY M. NAULT (SVP, GC & Secretary) sold 102,257 shares for an estimated $1,227,084
• KENNETH J WATKINSON (VP, Corporate Controller & CAO) sold 22,001 shares for an estimated $331,115
• PARAMITA DAS purchased 385 shares for an estimated $4,454

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CDE Hedge Fund Activity

We have seen 267 institutional investors add shares of CDE stock to their portfolio, and 240 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VAN ECK ASSOCIATES CORP added 23,646,265 shares (+55.8%) to their portfolio in Q3 2025, for an estimated $443,603,931
• NORGES BANK added 6,680,393 shares (+1283.9%) to their portfolio in Q4 2025, for an estimated $119,111,407
• MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 6,352,828 shares (+36.3%) to their portfolio in Q3 2025, for an estimated $119,179,053
• GOLDMAN SACHS GROUP INC added 6,012,718 shares (+92.6%) to their portfolio in Q4 2025, for an estimated $107,206,761
• PRICE T ROWE ASSOCIATES INC /MD/ added 5,028,336 shares (+114.3%) to their portfolio in Q3 2025, for an estimated $94,331,583
• VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 4,008,776 shares (-83.3%) from their portfolio in Q3 2025, for an estimated $75,204,637
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 3,982,085 shares (+38.6%) to their portfolio in Q3 2025, for an estimated $74,703,914

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CDE Analyst Ratings

Wall Street analysts have issued reports on $CDE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• TD Securities issued a "Buy" rating on 11/11/2025

To track analyst ratings and price targets for CDE, check out Quiver Quantitative's $CDE forecast page.

CDE Price Targets

Multiple analysts have issued price targets for $CDE recently. We have seen 3 analysts offer price targets for $CDE in the last 6 months, with a median target of $25.0.

Here are some recent targets:

• Josh Wolfson from RBC Capital set a target price of $26.0 on 02/12/2026
• Joe Reagor from Roth Capital set a target price of $23.0 on 12/15/2025
• Wayne Lam from TD Securities set a target price of $25.0 on 11/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of KILROY REALTY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"VISN 21 VA facilities modernization Marine Corps Air Station Miramar flight regulations Corporate State and Local Tax Deduction"

You can find more data on corporate lobbying on Quiver Quantitative.

KRC Hedge Fund Activity

We have seen 214 institutional investors add shares of KRC stock to their portfolio, and 150 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• D1 CAPITAL PARTNERS L.P. added 6,595,654 shares (+349.5%) to their portfolio in Q3 2025, for an estimated $278,666,381
• CANADA PENSION PLAN INVESTMENT BOARD removed 2,839,216 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $119,956,876
• M&T BANK CORP added 2,748,704 shares (+34820.2%) to their portfolio in Q4 2025, for an estimated $102,719,068
• FMR LLC added 2,672,323 shares (+61.1%) to their portfolio in Q3 2025, for an estimated $112,905,646
• DEUTSCHE BANK AG\ added 2,167,412 shares (+3356.0%) to their portfolio in Q3 2025, for an estimated $91,573,157
• PRUDENTIAL FINANCIAL INC removed 1,672,685 shares (-98.4%) from their portfolio in Q3 2025, for an estimated $70,670,941
• ROUTE ONE INVESTMENT COMPANY, L.P. added 1,618,711 shares (+161.7%) to their portfolio in Q3 2025, for an estimated $68,390,539

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

KRC Analyst Ratings

Wall Street analysts have issued reports on $KRC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 10/13/2025
• Scotiabank issued a "Sector Underperform" rating on 08/28/2025
• Goldman Sachs issued a "Sell" rating on 08/21/2025

To track analyst ratings and price targets for KRC, check out Quiver Quantitative's $KRC forecast page.

KRC Price Targets

Multiple analysts have issued price targets for $KRC recently. We have seen 10 analysts offer price targets for $KRC in the last 6 months, with a median target of $43.0.

Here are some recent targets:

• Nicholas Yulico from Scotiabank set a target price of $42.0 on 01/14/2026
• Vikram Malhotra from Mizuho set a target price of $37.0 on 12/12/2025
• Brendan Lynch from Barclays set a target price of $42.0 on 12/01/2025
• Blaine Heck from Wells Fargo set a target price of $41.0 on 11/25/2025
• John Kim from BMO Capital set a target price of $44.0 on 11/18/2025
• Steve Sakwa from Evercore ISI Group set a target price of $46.0 on 11/14/2025
• Michael Carroll from RBC Capital set a target price of $47.0 on 11/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$90,000 of FREEDOM HOLDING CORP lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Support for the development of critical minerals in Kazakhstan. HR 1024, US-Kazakhstan Trade Modernization Act. Matters relating to financial services."

You can find more data on corporate lobbying on Quiver Quantitative.

FRHC Insider Trading Activity

FRHC insiders have traded $FRHC stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $FRHC stock by insiders over the last 6 months:

• SERGEY LUKYANOV (*See Remarks) purchased 5,725 shares for an estimated $982,810
• AZAMAT YERDESSOV (Freedom Life Chief Exec. Ofc.) sold 2,007 shares for an estimated $355,239

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FRHC Hedge Fund Activity

We have seen 78 institutional investors add shares of FRHC stock to their portfolio, and 65 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST TRUST ADVISORS LP added 183,532 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,591,363
• MORGAN STANLEY added 73,088 shares (+59.5%) to their portfolio in Q3 2025, for an estimated $12,580,637
• TUDOR INVESTMENT CORP ET AL removed 61,977 shares (-85.9%) from their portfolio in Q3 2025, for an estimated $10,668,101
• JPMORGAN CHASE & CO added 49,712 shares (+188.6%) to their portfolio in Q3 2025, for an estimated $8,556,926
• CITADEL ADVISORS LLC added 45,876 shares (+177.2%) to their portfolio in Q3 2025, for an estimated $7,896,635
• D. E. SHAW & CO., INC. removed 28,246 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $4,861,983
• AQR CAPITAL MANAGEMENT LLC added 26,562 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,572,117

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of AXOGEN INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues relating to sensation loss after mastectomy."

You can find more data on corporate lobbying on Quiver Quantitative.

AXGN Insider Trading Activity

AXGN insiders have traded $AXGN stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.

Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:

• WILLIAM P. MR. BURKE has made 0 purchases and 13 sales selling 132,463 shares for an estimated $2,821,444.
• MICHAEL D DALE (Chief Executive Officer) has made 0 purchases and 2 sales selling 86,463 shares for an estimated $2,668,137.
• JOHN JOHNSON has made 0 purchases and 4 sales selling 45,379 shares for an estimated $1,390,392.
• KATHY JOHNSON WEILER has made 0 purchases and 3 sales selling 46,653 shares for an estimated $1,378,475.
• AMY MCBRIDE WENDELL has made 0 purchases and 3 sales selling 43,684 shares for an estimated $1,280,465.
• LINDSEY MARIE HARTLEY (CFO) has made 0 purchases and 3 sales selling 29,199 shares for an estimated $896,298.
• JOSEPH A. TYNDALL has made 0 purchases and 2 sales selling 25,108 shares for an estimated $777,770.
• MARC A BEGAN (EVP & General Counsel) has made 0 purchases and 2 sales selling 22,500 shares for an estimated $686,207.
• PAUL THOMAS sold 21,399 shares for an estimated $633,709
• ERICK WAYNE DEVINNEY (Chief Innovation Officer) has made 0 purchases and 2 sales selling 20,654 shares for an estimated $627,608.
• JENS KEMP (Chief Marketing Officer) sold 8,156 shares for an estimated $254,532

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AXGN Hedge Fund Activity

We have seen 97 institutional investors add shares of AXGN stock to their portfolio, and 82 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST LIGHT ASSET MANAGEMENT, LLC added 1,276,487 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $22,772,528
• BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
• BALYASNY ASSET MANAGEMENT L.P. removed 551,516 shares (-28.6%) from their portfolio in Q3 2025, for an estimated $9,839,045
• QUBE RESEARCH & TECHNOLOGIES LTD removed 545,153 shares (-74.8%) from their portfolio in Q3 2025, for an estimated $9,725,529
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 459,707 shares (+1578.6%) to their portfolio in Q3 2025, for an estimated $8,201,172
• MARSHALL WACE, LLP removed 454,126 shares (-70.8%) from their portfolio in Q3 2025, for an estimated $8,101,607
• SQUAREPOINT OPS LLC removed 407,671 shares (-84.3%) from their portfolio in Q3 2025, for an estimated $7,272,850

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AXGN Analyst Ratings

Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 12/05/2025
• Mizuho issued a "Outperform" rating on 12/01/2025
• Canaccord Genuity issued a "Buy" rating on 10/30/2025
• Citizens issued a "Market Outperform" rating on 10/30/2025
• Raymond James issued a "Outperform" rating on 10/30/2025

To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.

AXGN Price Targets

Multiple analysts have issued price targets for $AXGN recently. We have seen 7 analysts offer price targets for $AXGN in the last 6 months, with a median target of $37.0.

Here are some recent targets:

• Yi Chen from HC Wainwright & Co. set a target price of $39.0 on 12/05/2025
• Caitlin Cronin from Canaccord Genuity set a target price of $37.0 on 12/05/2025
• Frank Takkinen from Lake Street set a target price of $40.0 on 12/04/2025
• Michael Sarcone from Jefferies set a target price of $36.0 on 12/04/2025
• Anthony Petrone from Mizuho set a target price of $40.0 on 12/01/2025
• David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
• Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"medicare fee schedule and coverage for skin cancer treatments"

You can find more data on corporate lobbying on Quiver Quantitative.

SRTS Insider Trading Activity

SRTS insiders have traded $SRTS stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:

• JOSEPH C SARDANO (CHIEF EXECUTIVE OFFICER) purchased 25,000 shares for an estimated $100,750
• ERIC SACHETTA has made 2 purchases buying 9,500 shares for an estimated $38,760 and 0 sales.
• MICHAEL SARDANO (PRESIDENT AND GENERAL COUNSEL) has made 3 purchases buying 3,000 shares for an estimated $11,430 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SRTS Hedge Fund Activity

We have seen 13 institutional investors add shares of SRTS stock to their portfolio, and 24 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 668,880 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,100,283
• PERRITT CAPITAL MANAGEMENT INC removed 469,692 shares (-78.9%) from their portfolio in Q3 2025, for an estimated $1,474,832
• ACADIAN ASSET MANAGEMENT LLC removed 148,282 shares (-39.3%) from their portfolio in Q3 2025, for an estimated $465,605
• DIVISADERO STREET CAPITAL MANAGEMENT, LP added 128,224 shares (+39.5%) to their portfolio in Q3 2025, for an estimated $402,623
• PACIFIC RIDGE CAPITAL PARTNERS, LLC added 125,245 shares (+21.8%) to their portfolio in Q4 2025, for an estimated $498,475
• MEROS INVESTMENT MANAGEMENT, LP added 74,749 shares (+75.3%) to their portfolio in Q3 2025, for an estimated $234,711
• GSA CAPITAL PARTNERS LLP removed 71,696 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $225,125

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SRTS Analyst Ratings

Wall Street analysts have issued reports on $SRTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for SRTS, check out Quiver Quantitative's $SRTS forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$20,000 of SOUTHEASTERN COMMUNITY COLLEGE lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

EML Insider Trading Activity

EML insiders have traded $EML stock on the open market 25 times in the past 6 months. Of those trades, 25 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $EML stock by insiders over the last 6 months:

• FREDERICK D. DISANTO has made 16 purchases buying 15,505 shares for an estimated $323,442 and 0 sales.
• JAMES A MITAROTONDA has made 4 purchases buying 6,672 shares for an estimated $132,079 and 0 sales.
• JOHN EVERETS purchased 1,435 shares for an estimated $28,054
• MICHAEL J MARDY purchased 1,177 shares for an estimated $23,010
• PEGGY SCOTT purchased 1,140 shares for an estimated $22,287
• CHARLES W HENRY purchased 1,059 shares for an estimated $20,703
• CHAN GALBATO purchased 1,029 shares for an estimated $20,116

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EML Hedge Fund Activity

We have seen 39 institutional investors add shares of EML stock to their portfolio, and 26 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ROYAL BANK OF CANADA removed 22,120 shares (-98.2%) from their portfolio in Q3 2025, for an estimated $518,935
• JANNEY MONTGOMERY SCOTT LLC removed 18,745 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $439,757
• FIRST TRUST ADVISORS LP removed 18,455 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $432,954
• GATEPASS CAPITAL, LLC added 15,800 shares (+87.8%) to their portfolio in Q3 2025, for an estimated $370,668
• SEGALL BRYANT & HAMILL, LLC removed 12,680 shares (-43.2%) from their portfolio in Q3 2025, for an estimated $297,472
• TETON ADVISORS, LLC removed 11,365 shares (-8.1%) from their portfolio in Q4 2025, for an estimated $223,776
• JANE STREET GROUP, LLC added 10,389 shares (+inf%) to their portfolio in Q3 2025, for an estimated $243,725

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of ONTO INNOVATION INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to trade, export controls and tariffs. Issues related to export controls"

You can find more data on corporate lobbying on Quiver Quantitative.

ONTO Hedge Fund Activity

We have seen 257 institutional investors add shares of ONTO stock to their portfolio, and 242 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP added 1,292,772 shares (+1217.0%) to their portfolio in Q3 2025, for an estimated $167,051,997
• BLACKROCK, INC. removed 1,272,021 shares (-19.6%) from their portfolio in Q3 2025, for an estimated $164,370,553
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 984,457 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $127,211,533
• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 882,901 shares (+80.3%) to their portfolio in Q3 2025, for an estimated $114,088,467
• VOYA INVESTMENT MANAGEMENT LLC added 849,702 shares (+4494.6%) to their portfolio in Q3 2025, for an estimated $109,798,492
• QUBE RESEARCH & TECHNOLOGIES LTD removed 775,499 shares (-86.1%) from their portfolio in Q3 2025, for an estimated $100,209,980
• RAFFERTY ASSET MANAGEMENT, LLC removed 639,566 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $82,644,718

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ONTO Analyst Ratings

Wall Street analysts have issued reports on $ONTO in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 01/20/2026
• B. Riley Securities issued a "Buy" rating on 01/15/2026
• Oppenheimer issued a "Outperform" rating on 10/14/2025
• Jefferies issued a "Buy" rating on 09/23/2025

To track analyst ratings and price targets for ONTO, check out Quiver Quantitative's $ONTO forecast page.

ONTO Price Targets

Multiple analysts have issued price targets for $ONTO recently. We have seen 6 analysts offer price targets for $ONTO in the last 6 months, with a median target of $190.0.

Here are some recent targets:

• Charles Shi from Needham set a target price of $260.0 on 01/20/2026
• Craig Ellis from B. Riley Securities set a target price of $240.0 on 01/15/2026
• Brian Chin from Stifel set a target price of $180.0 on 01/14/2026
• Blayne Curtis from Jefferies set a target price of $200.0 on 12/15/2025
• Mark Lipacis from Evercore ISI Group set a target price of $160.0 on 11/05/2025
• Edward Yang from Oppenheimer set a target price of $180.0 on 10/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of MIMEDX lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"regulatory issues related to the delivery of wound management and skin substitutes for Medicare patients"

You can find more data on corporate lobbying on Quiver Quantitative.

MDXG Insider Trading Activity

MDXG insiders have traded $MDXG stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MDXG stock by insiders over the last 6 months:

• KIMBERLY MAERSK-MOLLER (Chief Commercial Officer) sold 58,300 shares for an estimated $432,329

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MDXG Hedge Fund Activity

We have seen 103 institutional investors add shares of MDXG stock to their portfolio, and 105 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST LIGHT ASSET MANAGEMENT, LLC added 1,725,458 shares (+89.5%) to their portfolio in Q3 2025, for an estimated $12,043,696
• NANTAHALA CAPITAL MANAGEMENT, LLC added 1,466,566 shares (+inf%) to their portfolio in Q3 2025, for an estimated $10,236,630
• DISCIPLINED GROWTH INVESTORS INC /MN added 1,022,202 shares (+283.0%) to their portfolio in Q3 2025, for an estimated $7,134,969
• TRIGRAN INVESTMENTS, INC. removed 689,430 shares (-8.2%) from their portfolio in Q3 2025, for an estimated $4,812,221
• MILLENNIUM MANAGEMENT LLC removed 534,790 shares (-32.0%) from their portfolio in Q3 2025, for an estimated $3,732,834
• AQR CAPITAL MANAGEMENT LLC added 510,017 shares (+1502.8%) to their portfolio in Q3 2025, for an estimated $3,559,918
• GOLDMAN SACHS GROUP INC added 480,476 shares (+62.7%) to their portfolio in Q3 2025, for an estimated $3,353,722

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MDXG Analyst Ratings

Wall Street analysts have issued reports on $MDXG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 12/17/2025

To track analyst ratings and price targets for MDXG, check out Quiver Quantitative's $MDXG forecast page.

MDXG Price Targets

Multiple analysts have issued price targets for $MDXG recently. We have seen 2 analysts offer price targets for $MDXG in the last 6 months, with a median target of $10.0.

Here are some recent targets:

• Brooks O'Neil from Lake Street set a target price of $10.0 on 01/20/2026
• Anthony Petrone from Mizuho set a target price of $10.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of TEXAS INSTRUMENTS INCORPORATED lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

TXN Congressional Stock Trading

Members of Congress have traded $TXN stock 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $TXN stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 12/18, 11/13, 08/14.
• REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 11/26.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 10/10.
• SENATOR MARKWAYNE MULLIN sold up to $50,000 on 09/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TXN Insider Trading Activity

TXN insiders have traded $TXN stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $TXN stock by insiders over the last 6 months:

• RONALD KIRK sold 9,990 shares for an estimated $1,621,687
• AHMAD BAHAI (Sr. Vice President) sold 1,500 shares for an estimated $308,030
• CHRISTINE WITZSCHE (Sr. Vice President) sold 1,000 shares for an estimated $164,306

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TXN Hedge Fund Activity

We have seen 999 institutional investors add shares of TXN stock to their portfolio, and 1,223 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 5,774,791 shares (+53.9%) to their portfolio in Q3 2025, for an estimated $1,061,002,350
• AMUNDI added 3,580,147 shares (+61.0%) to their portfolio in Q3 2025, for an estimated $657,780,408
• CITADEL ADVISORS LLC removed 3,466,542 shares (-91.6%) from their portfolio in Q3 2025, for an estimated $636,907,761
• SOUNDWATCH CAPITAL LLC removed 2,972,576 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $546,151,388
• JPMORGAN CHASE & CO removed 2,943,633 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $540,833,691
• INVESCO LTD. added 2,366,695 shares (+16.8%) to their portfolio in Q3 2025, for an estimated $434,832,872
• WELLINGTON MANAGEMENT GROUP LLP removed 2,188,631 shares (-11.4%) from their portfolio in Q3 2025, for an estimated $402,117,173

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TXN Analyst Ratings

Wall Street analysts have issued reports on $TXN in the last several months. We have seen 6 firms issue buy ratings on the stock, and 2 firms issue sell ratings.

Here are some recent analyst ratings:

• JP Morgan issued a "Overweight" rating on 01/28/2026
• Benchmark issued a "Buy" rating on 01/28/2026
• Mizuho issued a "Underperform" rating on 01/28/2026
• Rosenblatt issued a "Buy" rating on 01/28/2026
• Susquehanna issued a "Positive" rating on 10/22/2025
• Goldman Sachs issued a "Buy" rating on 10/22/2025
• TD Cowen issued a "Buy" rating on 10/22/2025

To track analyst ratings and price targets for TXN, check out Quiver Quantitative's $TXN forecast page.

TXN Price Targets

Multiple analysts have issued price targets for $TXN recently. We have seen 18 analysts offer price targets for $TXN in the last 6 months, with a median target of $225.0.

Here are some recent targets:

• Kevin Cassidy from Rosenblatt set a target price of $240.0 on 02/05/2026
• Ross Seymore from Deutsche Bank set a target price of $205.0 on 01/28/2026
• Cody Acree from Benchmark set a target price of $250.0 on 01/28/2026
• Harlan Sur from JP Morgan set a target price of $227.0 on 01/28/2026
• Blayne Curtis from Jefferies set a target price of $210.0 on 01/28/2026
• James Schneider from Goldman Sachs set a target price of $175.0 on 01/28/2026
• Timothy Arcuri from UBS set a target price of $260.0 on 01/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$150,000 of CORMEDIX INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 2172/S. 1058, Preserving Patient Access to Home Infusion Act H.R. 6214/S. 2730, Kidney Care Access Protection Act"

You can find more data on corporate lobbying on Quiver Quantitative.

CRMD Insider Trading Activity

CRMD insiders have traded $CRMD stock on the open market 15 times in the past 6 months. Of those trades, 1 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $CRMD stock by insiders over the last 6 months:

• JANET DILLIONE has made 0 purchases and 5 sales selling 147,000 shares for an estimated $1,547,555.
• JOSEPH TODISCO (Chief Executive Officer) has made 0 purchases and 2 sales selling 80,000 shares for an estimated $1,010,000.
• ELIZABETH HURLBURT (Chief Operating Officer) has made 0 purchases and 2 sales selling 53,997 shares for an estimated $711,817.
• KAUFMAN BETH ZELNICK (Chief Legal Officer) has made 0 purchases and 2 sales selling 50,000 shares for an estimated $670,264.
• STEVEN W LEFKOWITZ sold 40,000 shares for an estimated $475,200
• ALAN W DUNTON has made 0 purchases and 2 sales selling 30,000 shares for an estimated $391,300.
• MYRON KAPLAN purchased 25,000 shares for an estimated $275,500

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CRMD Hedge Fund Activity

We have seen 144 institutional investors add shares of CRMD stock to their portfolio, and 71 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• DEERFIELD MANAGEMENT COMPANY, L.P. added 3,323,833 shares (+inf%) to their portfolio in Q3 2025, for an estimated $38,656,177
• MARSHALL WACE, LLP added 893,518 shares (+34.6%) to their portfolio in Q3 2025, for an estimated $10,391,614
• JUMP FINANCIAL, LLC added 774,083 shares (+inf%) to their portfolio in Q3 2025, for an estimated $9,002,585
• NUVEEN, LLC removed 772,997 shares (-52.6%) from their portfolio in Q3 2025, for an estimated $8,989,955
• GHISALLO CAPITAL MANAGEMENT LLC removed 750,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,722,500
• ANSON FUNDS MANAGEMENT LP removed 725,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,431,750
• RAYMOND JAMES FINANCIAL INC added 564,688 shares (+646.8%) to their portfolio in Q3 2025, for an estimated $6,567,321

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CRMD Analyst Ratings

Wall Street analysts have issued reports on $CRMD in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 01/23/2026
• Needham issued a "Buy" rating on 01/08/2026
• D. Boral Capital issued a "Buy" rating on 12/18/2025
• RBC Capital issued a "Outperform" rating on 10/21/2025
• JMP Securities issued a "Market Outperform" rating on 09/09/2025

To track analyst ratings and price targets for CRMD, check out Quiver Quantitative's $CRMD forecast page.

CRMD Price Targets

Multiple analysts have issued price targets for $CRMD recently. We have seen 5 analysts offer price targets for $CRMD in the last 6 months, with a median target of $14.0.

Here are some recent targets:

• Brandon Folkes from HC Wainwright & Co. set a target price of $13.0 on 01/23/2026
• Leonid Timashev from RBC Capital set a target price of $13.0 on 01/21/2026
• Jason Kolbert from D. Boral Capital set a target price of $14.0 on 01/08/2026
• Serge Belanger from Needham set a target price of $15.0 on 01/08/2026
• Jason N. Butler from JMP Securities set a target price of $22.0 on 09/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$11,000 of RAYONIER lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Forestry Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

RYN Insider Trading Activity

RYN insiders have traded $RYN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $RYN stock by insiders over the last 6 months:

• CHRISTOPHER T CORR (SVP, Real Estate Development) sold 14,255 shares for an estimated $301,065

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RYN Hedge Fund Activity

We have seen 233 institutional investors add shares of RYN stock to their portfolio, and 152 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ removed 6,630,256 shares (-39.2%) from their portfolio in Q3 2025, for an estimated $175,966,994
• SOUTHEASTERN ASSET MANAGEMENT INC/TN/ added 4,496,725 shares (+inf%) to their portfolio in Q3 2025, for an estimated $119,343,081
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 747,545 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $19,839,844
• GOTHAM ASSET MANAGEMENT, LLC added 683,517 shares (+246.6%) to their portfolio in Q3 2025, for an estimated $18,140,541
• FULLER & THALER ASSET MANAGEMENT, INC. added 651,879 shares (+62.2%) to their portfolio in Q3 2025, for an estimated $17,300,868
• VICTORY CAPITAL MANAGEMENT INC removed 533,572 shares (-18.0%) from their portfolio in Q3 2025, for an estimated $14,161,000
• NUVEEN, LLC removed 507,763 shares (-61.7%) from their portfolio in Q3 2025, for an estimated $13,476,030

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RYN Price Targets

Multiple analysts have issued price targets for $RYN recently. We have seen 2 analysts offer price targets for $RYN in the last 6 months, with a median target of $25.0.

Here are some recent targets:

• Michael Roxland from Truist Securities set a target price of $26.0 on 01/06/2026
• Anthony Pettinari from Citigroup set a target price of $24.0 on 11/12/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$15,000 of CAREDX lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"None"

You can find more data on corporate lobbying on Quiver Quantitative.

CDNA Insider Trading Activity

CDNA insiders have traded $CDNA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $CDNA stock by insiders over the last 6 months:

• JOHN WALTER JR HANNA (President and CEO) has made 0 purchases and 3 sales selling 29,636 shares for an estimated $626,026.
• JEFFREY ADAM NOVACK (Secretary and General Counsel) has made 0 purchases and 4 sales selling 14,422 shares for an estimated $272,813.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CDNA Hedge Fund Activity

We have seen 94 institutional investors add shares of CDNA stock to their portfolio, and 111 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• INVESCO LTD. removed 2,433,674 shares (-95.7%) from their portfolio in Q3 2025, for an estimated $35,385,619
• DEERFIELD MANAGEMENT COMPANY, L.P. added 2,191,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,857,139
• BRAIDWELL LP added 2,182,781 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,737,635
• HOOD RIVER CAPITAL MANAGEMENT LLC removed 1,765,981 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $25,677,363
• NEXT CENTURY GROWTH INVESTORS LLC removed 1,125,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $16,364,101
• BAMCO INC /NY/ added 719,523 shares (+29.5%) to their portfolio in Q3 2025, for an estimated $10,461,864
• KENT LAKE PR LLC added 550,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,996,999

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CDNA Analyst Ratings

Wall Street analysts have issued reports on $CDNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BTIG issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for CDNA, check out Quiver Quantitative's $CDNA forecast page.

CDNA Price Targets

Multiple analysts have issued price targets for $CDNA recently. We have seen 2 analysts offer price targets for $CDNA in the last 6 months, with a median target of $21.5.

Here are some recent targets:

• Brandon Couillard from Wells Fargo set a target price of $18.0 on 12/15/2025
• Mark Massaro from BTIG set a target price of $25.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$100,000 of AMERICAN DENTAL EDUCATION ASSOCIATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Oral health workforce and research funding, higher education Oral health education funding and policy Higher education policy & student loan policy"

You can find more data on corporate lobbying on Quiver Quantitative.

TAL Hedge Fund Activity

We have seen 118 institutional investors add shares of TAL stock to their portfolio, and 91 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ASPEX MANAGEMENT (HK) LTD removed 21,586,517 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $241,768,990
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 13,942,562 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $156,156,694
• HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 7,197,100 shares (-63.5%) from their portfolio in Q3 2025, for an estimated $80,607,520
• SERENITY CAPITAL MANAGEMENT PTE. LTD. added 4,701,422 shares (+16237.0%) to their portfolio in Q3 2025, for an estimated $52,655,926
• KRANE FUNDS ADVISORS LLC added 4,684,426 shares (+25.5%) to their portfolio in Q3 2025, for an estimated $52,465,571
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,462,149 shares (+3989.3%) to their portfolio in Q3 2025, for an estimated $49,976,068
• CAPITOLIS LIQUID GLOBAL MARKETS LLC added 4,277,500 shares (+153.7%) to their portfolio in Q3 2025, for an estimated $47,908,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of DIEBOLD NIXDORF lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties."

You can find more data on corporate lobbying on Quiver Quantitative.

DBD Insider Trading Activity

DBD insiders have traded $DBD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $DBD stock by insiders over the last 6 months:

• CAPITAL MANAGEMENT LLC MILLSTREET has made 0 purchases and 5 sales selling 810,689 shares for an estimated $53,449,819.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DBD Hedge Fund Activity

We have seen 89 institutional investors add shares of DBD stock to their portfolio, and 62 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• HEIN PARK CAPITAL MANAGEMENT LP removed 868,339 shares (-68.5%) from their portfolio in Q3 2025, for an estimated $49,521,373
• GLENDON CAPITAL MANAGEMENT LP removed 370,396 shares (-23.9%) from their portfolio in Q3 2025, for an estimated $21,123,683
• ARENA CAPITAL ADVISORS, LLC- CA removed 366,530 shares (-37.5%) from their portfolio in Q3 2025, for an estimated $20,903,205
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 330,526 shares (+458.6%) to their portfolio in Q3 2025, for an estimated $18,849,897
• MEDINA VALUE PARTNERS, LLC removed 318,919 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $18,187,950
• BEACH POINT CAPITAL MANAGEMENT LP removed 213,753 shares (-13.6%) from their portfolio in Q3 2025, for an estimated $12,190,333
• AMERICAN CENTURY COMPANIES INC added 212,790 shares (+73.6%) to their portfolio in Q3 2025, for an estimated $12,135,413

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DBD Analyst Ratings

Wall Street analysts have issued reports on $DBD in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Outperform" rating on 11/18/2025
• DA Davidson issued a "Buy" rating on 08/19/2025

To track analyst ratings and price targets for DBD, check out Quiver Quantitative's $DBD forecast page.

DBD Price Targets

Multiple analysts have issued price targets for $DBD recently. We have seen 2 analysts offer price targets for $DBD in the last 6 months, with a median target of $80.0.

Here are some recent targets:

• Antoine Legault from Wedbush set a target price of $80.0 on 11/18/2025
• Matthew Summerville from DA Davidson set a target price of $80.0 on 08/19/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$10,000 of BRINKS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties. The Payment Choice Act of 2025 - Summary A bipartisan bill introduced in the Senate and House of Representatives. Its purpose is to ensure that businesses accept cash for on-site sales under $500 and cannot charge cash-paying customers a higher price than those using other payment methods. The bill allows for exceptions, such as a business providing a fee-free device to convert cash to a prepaid card. S. 2326 - Payment Choice Act of 2025 1119th Congress (2025-2026) - Introduced in Senate 07/17/2025 Sponsor: Sen. Cramer, Kevin [R-ND] Committees: Senate - Banking, Housing, Urban Affairs To ensure that United States currency is treated as legal tender to be accepted as payment for purchases of goods and services at brick-and-mortar businesses throughout the United States, and for other purposes. H.R.1138 - Payment Choice Act of 2025 119th Congress (2025-2026) - Introduced in House 02/07/2025 Sponsor: Rep. Rose, John W. [R=TN-6] Committees: House - Financial Affairs This bill requires retail businesses to accept cash as a form of payment for on-site sales of $500 or less and it prohibits them from charging cash-paying customers a higher price compared to customers not paying with cash. Businesses covered by this bill are those engaged in the business of selling or offering goods or services at retail to the public that accept in-person payments at a physical location. The bill establishes exceptions for this requirement, including by allowing a business to provide a device to provide prepaid cards on site for customers to use as payment. Among other requirements, such a card must not have a fee associated with its use and must not require a minimum payment of more than $1. The bill provides for enforcement through preventative relief, damages, and civil penalties."

You can find more data on corporate lobbying on Quiver Quantitative.

BCO Congressional Stock Trading

Members of Congress have traded $BCO stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BCO stock by members of Congress over the last 6 months:

• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BCO Insider Trading Activity

BCO insiders have traded $BCO stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $BCO stock by insiders over the last 6 months:

• DANIEL J CASTILLO (EVP) has made 0 purchases and 2 sales selling 21,700 shares for an estimated $2,380,558.
• MICHAEL E SWEENEY (Controller) has made 0 purchases and 7 sales selling 5,273 shares for an estimated $576,587.
• ARTHELBERT LOUIS PARKER sold 540 shares for an estimated $62,100
• KEITH R WYCHE sold 475 shares for an estimated $50,421

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BCO Hedge Fund Activity

We have seen 156 institutional investors add shares of BCO stock to their portfolio, and 161 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AMERICAN CENTURY COMPANIES INC removed 442,803 shares (-26.8%) from their portfolio in Q3 2025, for an estimated $51,745,958
• FMR LLC removed 372,007 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $43,472,738
• FOURTH SAIL CAPITAL LP removed 281,500 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $32,896,090
• FIRST TRUST ADVISORS LP added 195,466 shares (+48.2%) to their portfolio in Q3 2025, for an estimated $22,842,156
• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 193,114 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $22,567,302
• LSV ASSET MANAGEMENT added 175,773 shares (+16.3%) to their portfolio in Q3 2025, for an estimated $20,540,832
• BARCLAYS PLC added 162,677 shares (+78.2%) to their portfolio in Q3 2025, for an estimated $19,010,434

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of BROWNSTEIN HYATT FARBER AND SCHRECK ON BEHALF OF ROYAL CARIBBEAN CRUISES LTD lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General issues related to cruise ship industry"

You can find more data on corporate lobbying on Quiver Quantitative.

RCL Congressional Stock Trading

Members of Congress have traded $RCL stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $RCL stock by members of Congress over the last 6 months:

• REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

RCL Insider Trading Activity

RCL insiders have traded $RCL stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $RCL stock by insiders over the last 6 months:

• RICHARD D FAIN has made 0 purchases and 3 sales selling 16,000 shares for an estimated $4,976,286.
• VAGN O SORENSEN sold 10,300 shares for an estimated $3,399,412
• MARITZA GOMEZ MONTIEL sold 1,100 shares for an estimated $309,936

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

RCL Hedge Fund Activity

We have seen 568 institutional investors add shares of RCL stock to their portfolio, and 553 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 6,611,624 shares (-25.6%) from their portfolio in Q3 2025, for an estimated $2,139,389,293
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,540,491 shares (-99.4%) from their portfolio in Q3 2025, for an estimated $498,472,077
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 996,961 shares (-37.9%) from their portfolio in Q3 2025, for an estimated $322,596,640
• GOLDMAN SACHS GROUP INC added 969,574 shares (+52.4%) to their portfolio in Q3 2025, for an estimated $313,734,754
• BANK OF NEW YORK MELLON CORP removed 852,083 shares (-28.2%) from their portfolio in Q3 2025, for an estimated $275,717,017
• CAPITAL WORLD INVESTORS removed 843,439 shares (-4.7%) from their portfolio in Q3 2025, for an estimated $272,919,991
• PRICE T ROWE ASSOCIATES INC /MD/ added 751,170 shares (+85.9%) to their portfolio in Q3 2025, for an estimated $243,063,588

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

RCL Analyst Ratings

Wall Street analysts have issued reports on $RCL in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 02/02/2026
• Stifel issued a "Buy" rating on 01/30/2026
• Barclays issued a "Overweight" rating on 01/30/2026
• Goldman Sachs issued a "Buy" rating on 12/09/2025
• UBS issued a "Buy" rating on 11/12/2025
• Citigroup issued a "Buy" rating on 10/29/2025
• Tigress Financial issued a "Buy" rating on 08/21/2025

To track analyst ratings and price targets for RCL, check out Quiver Quantitative's $RCL forecast page.

RCL Price Targets

Multiple analysts have issued price targets for $RCL recently. We have seen 13 analysts offer price targets for $RCL in the last 6 months, with a median target of $370.0.

Here are some recent targets:

• Jamie Rollo from Morgan Stanley set a target price of $330.0 on 02/03/2026
• Trey Bowers from Wells Fargo set a target price of $383.0 on 02/02/2026
• Matthew Boss from JP Morgan set a target price of $371.0 on 02/02/2026
• Lizzie Dove from Goldman Sachs set a target price of $370.0 on 02/02/2026
• James Hardiman from Citigroup set a target price of $398.0 on 02/02/2026
• Brandt Montour from Barclays set a target price of $361.0 on 01/30/2026
• Steven Wieczynski from Stifel set a target price of $420.0 on 01/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$60,000 of PG&E lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Energy and Utilites."

You can find more data on corporate lobbying on Quiver Quantitative.

PCG Congressional Stock Trading

Members of Congress have traded $PCG stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PCG stock by members of Congress over the last 6 months:

• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PCG Insider Trading Activity

PCG insiders have traded $PCG stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $PCG stock by insiders over the last 6 months:

• JASON M GLICKMAN sold 29,473 shares for an estimated $470,094
• JOHN O LARSEN purchased 7,500 shares for an estimated $119,700
• III MARK E FERGUSON sold 7,000 shares for an estimated $106,050

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PCG Hedge Fund Activity

We have seen 469 institutional investors add shares of PCG stock to their portfolio, and 345 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS added 31,613,248 shares (+84.7%) to their portfolio in Q3 2025, for an estimated $476,727,779
• JPMORGAN CHASE & CO removed 23,960,148 shares (-41.5%) from their portfolio in Q3 2025, for an estimated $361,319,031
• AQR CAPITAL MANAGEMENT LLC added 21,912,919 shares (+88.8%) to their portfolio in Q3 2025, for an estimated $330,446,818
• CAPITAL INTERNATIONAL INVESTORS removed 12,884,953 shares (-26.6%) from their portfolio in Q3 2025, for an estimated $194,305,091
• MILLENNIUM MANAGEMENT LLC removed 12,401,803 shares (-63.9%) from their portfolio in Q3 2025, for an estimated $187,019,189
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 12,049,345 shares (+70.1%) to their portfolio in Q3 2025, for an estimated $181,704,122
• CITADEL ADVISORS LLC removed 9,950,954 shares (-65.3%) from their portfolio in Q3 2025, for an estimated $150,060,386

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PCG Analyst Ratings

Wall Street analysts have issued reports on $PCG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 01/28/2026
• Wells Fargo issued a "Overweight" rating on 01/20/2026
• BMO Capital issued a "Outperform" rating on 10/14/2025
• Barclays issued a "Overweight" rating on 10/01/2025

To track analyst ratings and price targets for PCG, check out Quiver Quantitative's $PCG forecast page.

PCG Price Targets

Multiple analysts have issued price targets for $PCG recently. We have seen 7 analysts offer price targets for $PCG in the last 6 months, with a median target of $21.0.

Here are some recent targets:

• Julien Dumoulin-Smith from Jefferies set a target price of $20.0 on 01/28/2026
• Shahriar Pourreza from Wells Fargo set a target price of $24.0 on 01/20/2026
• Richard Sunderland from JP Morgan set a target price of $21.0 on 12/12/2025
• Gregg Orrill from UBS set a target price of $18.0 on 10/24/2025
• James Thalacker from BMO Capital set a target price of $25.0 on 10/14/2025
• Nicholas Campanella from Barclays set a target price of $21.0 on 10/01/2025
• David Arcaro from Morgan Stanley set a target price of $19.5 on 09/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$21,000 of ENCORE ENERGY CORP. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Uranium Mining 1872 Mining Law Russian and Chinese Uranium Imports for Nuclear Power Generation 1872 Mining Law Nuclear Fuel Production"

You can find more data on corporate lobbying on Quiver Quantitative.

EU Insider Trading Activity

EU insiders have traded $EU stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $EU stock by insiders over the last 6 months:

• WILLIAM B. HARRIS sold 80,000 shares for an estimated $272,800
• WILLIAM M SHERIFF (See Remarks) has made 0 purchases and 4 sales selling 74,500 shares for an estimated $188,510.
• DENNIS STOVER has made 0 purchases and 2 sales selling 40,000 shares for an estimated $137,330.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EU Hedge Fund Activity

We have seen 82 institutional investors add shares of EU stock to their portfolio, and 42 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VAN ECK ASSOCIATES CORP added 6,933,454 shares (+76.7%) to their portfolio in Q3 2025, for an estimated $22,256,387
• SEGRA CAPITAL MANAGEMENT, LLC removed 3,770,728 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,104,036
• CITADEL ADVISORS LLC added 2,468,876 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,925,091
• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,970,831 shares (+326.2%) to their portfolio in Q3 2025, for an estimated $6,326,367
• LLOYD HARBOR CAPITAL MANAGEMENT, LLC added 1,900,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $6,099,000
• NOMURA HOLDINGS INC added 1,429,777 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,589,584
• TWO SIGMA INVESTMENTS, LP added 1,185,050 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,804,010

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

EU Analyst Ratings

Wall Street analysts have issued reports on $EU in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• HC Wainwright & Co. issued a "Buy" rating on 08/12/2025

To track analyst ratings and price targets for EU, check out Quiver Quantitative's $EU forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$150,000 of SUN LIFE FINANCIAL (U.S.) SERVICES COMPANY INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issue -- Medicaid Dental Benefits H.R.1 - One Big Beautiful Bill Act P.L.119-21 -- One Big Beautiful Bill Act S.2447 -- Repealing the Trump Sick Tax Act S.2084 -- Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2025 H.R.1397/S.1164 -- Increasing Access to Dental Insurance Act Issue -- ERISA E-Delivery for Health and Welfare Benefit Plans H.R.3758 -- Workers Disability Benefits Parity Act of 2025 Issue -- Medical Stop-Loss H.R.2571 -- Self-Insurance Protection Act S.2210 -- Unlocking Benefits for Independent Workers Act H.R.1320 -- To ensure that the provision of portable benefits to an individual is not considered in determining whether such individual is an employee of a person. H.R.6703 -- Lower Health Care Premiums for All Americans Act H.R.1521 -- Dental and Optometric Care Access (DOC Access) Act Issue -- Paid Family and Medical Leave Issue -- Rural Health Transformation Program S.2355/H.R.5582 -- Patients Deserve Price Tags Act H.R.5378 (118th) -- Lower Cost, More Transparency Act H.R.2547 -- Secure Family Futures Act H.R.1 -- One Big Beautiful Bill Act P.L.119-21 -- One Big Beautiful Bill Act P.L.117-169 -- Inflation Reduction Act H.R.996/S.400 -- Paid Family and Medical Leave Tax Credit Extension and Enhancement Act"

You can find more data on corporate lobbying on Quiver Quantitative.

SLF Hedge Fund Activity

We have seen 178 institutional investors add shares of SLF stock to their portfolio, and 200 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CIBC ASSET MANAGEMENT INC removed 2,098,682 shares (-38.0%) from their portfolio in Q3 2025, for an estimated $125,983,880
• MACKENZIE FINANCIAL CORP removed 1,882,037 shares (-17.2%) from their portfolio in Q3 2025, for an estimated $112,978,681
• BANK OF NOVA SCOTIA removed 1,443,539 shares (-23.4%) from their portfolio in Q3 2025, for an estimated $86,655,646
• PICTON MAHONEY ASSET MANAGEMENT removed 1,322,756 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $79,405,042
• ROYAL BANK OF CANADA removed 1,192,430 shares (-2.3%) from their portfolio in Q3 2025, for an estimated $71,581,572
• CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. removed 1,098,286 shares (-23.0%) from their portfolio in Q3 2025, for an estimated $65,930,108
• HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 1,005,000 shares (+251.3%) to their portfolio in Q3 2025, for an estimated $60,330,150

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SLF Analyst Ratings

Wall Street analysts have issued reports on $SLF in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Underweight" rating on 10/08/2025
• TD Securities issued a "Buy" rating on 10/08/2025

To track analyst ratings and price targets for SLF, check out Quiver Quantitative's $SLF forecast page.

SLF Price Targets

Multiple analysts have issued price targets for $SLF recently. We have seen 5 analysts offer price targets for $SLF in the last 6 months, with a median target of $87.0.

Here are some recent targets:

• Darko Mihelic from RBC Capital set a target price of $84.0 on 11/10/2025
• Mike Rizvanovic from Scotiabank set a target price of $87.0 on 11/07/2025
• Paul Holden from CIBC set a target price of $94.0 on 10/30/2025
• Alex Scott from Barclays set a target price of $84.0 on 10/08/2025
• Mario Mendonca from TD Securities set a target price of $101.0 on 10/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of QUANTA SERVICES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General aerial firefighting issues with USFS. H.R. 471, Fix our Forests. S. 160, Aerial Firefighting Enhancement Act of 2025. General aerial firefighting issues with USFS. H.R. 471, Fix our Forests. S. 160, Aerial Firefighting Enhancement Act of 2025. General energy issues - electric power, pipeline, industrial and communications industries. Update on the status of disaster repairs (for T&D infrastructure and utilities) and report on mitigation efforts in hurricane impacted areas (Harvey, Maria and Fiona). H.R. 471, Fix our Forests Act. Standardizing Permitting and Expediting Economic Development (SPEED) Act (H.R. 4776) General energy issues for this specialty contractor with the largest highly trained skilled workforce in North America - electric power, pipeline, industrial and communications industries. Update on the status of disaster repairs (for T&D infrastructure and utilities) and report on mitigation efforts in hurricane impacted areas (Harvey, Maria and Fiona)."

You can find more data on corporate lobbying on Quiver Quantitative.

PWR Congressional Stock Trading

Members of Congress have traded $PWR stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $PWR stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $45,000 on 11/18, 10/17, 09/12 and 2 sales worth up to $30,000 on 12/24, 12/19.
• REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/02, 11/17.
• REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PWR Insider Trading Activity

PWR insiders have traded $PWR stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $PWR stock by insiders over the last 6 months:

• DONALD WAYNE (EVP and General Counsel) has made 0 purchases and 5 sales selling 14,000 shares for an estimated $6,213,342.
• GERALD A JR DUCEY (Pres. - Strategic Operations) sold 7,653 shares for an estimated $3,413,850
• WORTHING JACKMAN sold 6,349 shares for an estimated $2,859,907
• BERNARD FRIED sold 4,000 shares for an estimated $1,808,760

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PWR Hedge Fund Activity

We have seen 730 institutional investors add shares of PWR stock to their portfolio, and 623 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 1,721,752 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $713,528,463
• CAPITAL WORLD INVESTORS removed 1,585,509 shares (-18.9%) from their portfolio in Q3 2025, for an estimated $657,066,639
• BANK OF AMERICA CORP /DE/ added 765,822 shares (+35.6%) to their portfolio in Q3 2025, for an estimated $317,371,953
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 718,261 shares (+54.7%) to their portfolio in Q3 2025, for an estimated $297,661,723
• VOYA INVESTMENT MANAGEMENT LLC removed 593,968 shares (-83.5%) from their portfolio in Q3 2025, for an estimated $246,152,218
• PRICE T ROWE ASSOCIATES INC /MD/ added 583,438 shares (+127.9%) to their portfolio in Q3 2025, for an estimated $241,788,375
• JPMORGAN CHASE & CO removed 292,390 shares (-4.3%) from their portfolio in Q3 2025, for an estimated $121,172,263

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PWR Analyst Ratings

Wall Street analysts have issued reports on $PWR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 11/03/2025
• Citigroup issued a "Buy" rating on 10/31/2025
• Stifel issued a "Buy" rating on 10/09/2025
• Evercore ISI Group issued a "Outperform" rating on 08/08/2025

To track analyst ratings and price targets for PWR, check out Quiver Quantitative's $PWR forecast page.

PWR Price Targets

Multiple analysts have issued price targets for $PWR recently. We have seen 10 analysts offer price targets for $PWR in the last 6 months, with a median target of $516.0.

Here are some recent targets:

• Andrew Kaplowitz from Citigroup set a target price of $540.0 on 01/26/2026
• Brian Brophy from Stifel set a target price of $517.0 on 01/26/2026
• Manish Somaiya from Cantor Fitzgerald set a target price of $520.0 on 01/23/2026
• Chad Dillard from Bernstein set a target price of $428.0 on 12/19/2025
• Mark Strouse from JP Morgan set a target price of $515.0 on 12/08/2025
• Julien Dumoulin-Smith from Jefferies set a target price of $517.0 on 11/03/2025
• Durgesh Chopra from Evercore ISI Group set a target price of $480.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$40,000 of DIVERSIFIED ENERGY COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Monitor and discuss general issues surrounding conventional and unconventional natural gas and liquids production, marketing, transport and well retirement. Monitor and discuss general issues surrounding conventional and unconventional natural gas and liquids production, marketing, transport and well retirement."

You can find more data on corporate lobbying on Quiver Quantitative.

DEC Insider Trading Activity

DEC insiders have traded $DEC stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DEC stock by insiders over the last 6 months:

• RANDALL S. WADE sold 2,100,000 shares for an estimated $27,888,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DEC Hedge Fund Activity

We have seen 93 institutional investors add shares of DEC stock to their portfolio, and 59 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AMERIPRISE FINANCIAL INC added 4,108,991 shares (+inf%) to their portfolio in Q3 2025, for an estimated $57,566,963
• JUPITER ASSET MANAGEMENT LTD removed 2,926,886 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $41,005,672
• ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,000,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $14,010,000
• VANGUARD GROUP INC removed 974,894 shares (-24.8%) from their portfolio in Q4 2025, for an estimated $14,116,465
• ABERDEEN GROUP PLC added 959,988 shares (+inf%) to their portfolio in Q4 2025, for an estimated $13,900,626
• CITADEL ADVISORS LLC added 767,378 shares (+47.6%) to their portfolio in Q3 2025, for an estimated $10,750,965
• KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 626,014 shares (-29.7%) from their portfolio in Q3 2025, for an estimated $8,770,456

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DEC Analyst Ratings

Wall Street analysts have issued reports on $DEC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Mizuho issued a "Outperform" rating on 12/12/2025
• Clear Street issued a "Buy" rating on 11/25/2025
• William Blair issued a "Outperform" rating on 11/18/2025
• Citigroup issued a "Buy" rating on 11/13/2025

To track analyst ratings and price targets for DEC, check out Quiver Quantitative's $DEC forecast page.

DEC Price Targets

Multiple analysts have issued price targets for $DEC recently. We have seen 4 analysts offer price targets for $DEC in the last 6 months, with a median target of $24.0.

Here are some recent targets:

• Nitin Kumar from Mizuho set a target price of $27.0 on 12/12/2025
• Charles Meade from Johnson Rice set a target price of $23.0 on 12/05/2025
• Tim Moore from Clear Street set a target price of $25.0 on 11/25/2025
• Paul Diamond from Citigroup set a target price of $17.0 on 11/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$100,000 of NRG ENERGY INC lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Permitting reform, co-location/data centers, and FCC Docket Number 25-110"

You can find more data on corporate lobbying on Quiver Quantitative.

NRG Insider Trading Activity

NRG insiders have traded $NRG stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $NRG stock by insiders over the last 6 months:

• BRIAN CURCI (Exec VP & General Counsel) has made 0 purchases and 2 sales selling 107,556 shares for an estimated $17,258,059.
• ROBERT J GAUDETTE (Exec VP, NRG Business) sold 45,000 shares for an estimated $7,144,200
• VIRGINIA KINNEY (Exec VP, Chief Admin Officer) sold 20,000 shares for an estimated $3,276,400
• BRUCE CHUNG (EVP & CFO) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $3,148,134.
• DAK LIYANEARACHCHI (Exec VP, Chief Technology Ofc.) sold 10,672 shares for an estimated $1,654,160

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NRG Hedge Fund Activity

We have seen 520 institutional investors add shares of NRG stock to their portfolio, and 507 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 5,202,627 shares (+54.9%) to their portfolio in Q3 2025, for an estimated $842,565,442
• BANCO SANTANDER, S.A. removed 2,206,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $357,261,700
• GOLDMAN SACHS GROUP INC removed 1,832,544 shares (-57.6%) from their portfolio in Q3 2025, for an estimated $296,780,500
• JANE STREET GROUP, LLC removed 1,573,503 shares (-67.0%) from their portfolio in Q3 2025, for an estimated $254,828,810
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,332,394 shares (+85.8%) to their portfolio in Q3 2025, for an estimated $215,781,208
• HOLOCENE ADVISORS, LP removed 1,149,645 shares (-79.6%) from their portfolio in Q3 2025, for an estimated $186,185,007
• LSV ASSET MANAGEMENT removed 1,098,044 shares (-70.7%) from their portfolio in Q3 2025, for an estimated $177,828,225

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NRG Analyst Ratings

Wall Street analysts have issued reports on $NRG in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 01/27/2026
• Wells Fargo issued a "Overweight" rating on 10/28/2025
• Melius Research issued a "Buy" rating on 08/20/2025
• Barclays issued a "Overweight" rating on 08/07/2025

To track analyst ratings and price targets for NRG, check out Quiver Quantitative's $NRG forecast page.

NRG Price Targets

Multiple analysts have issued price targets for $NRG recently. We have seen 9 analysts offer price targets for $NRG in the last 6 months, with a median target of $203.0.

Here are some recent targets:

• Julien Dumoulin-Smith from Jefferies set a target price of $181.0 on 01/27/2026
• Shahriar Pourreza from Wells Fargo set a target price of $206.0 on 01/20/2026
• William Appicelli from UBS set a target price of $211.0 on 12/09/2025
• James Thalacker from BMO Capital set a target price of $195.0 on 11/07/2025
• Stephen Byrd from Morgan Stanley set a target price of $144.0 on 10/28/2025
• Angie Storozynski from Seaport Global set a target price of $202.0 on 10/08/2025
• Andrew Weisel from Scotiabank set a target price of $212.0 on 09/22/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$390,000 of NATIONAL FUEL GAS COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"LIHEAP, pipeline permitting reform, climate change policy, pipeline safety reauthorization, energy policy (including renewable natural gas and hydrogen), energy choice, natural gas appliances , federal oversight of natural gas use, Energy Star program, pipeline security & cybersecurity, natural gas use in federal facilities, federal tax policy."

You can find more data on corporate lobbying on Quiver Quantitative.

NFG Hedge Fund Activity

We have seen 306 institutional investors add shares of NFG stock to their portfolio, and 255 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• AQR CAPITAL MANAGEMENT LLC added 1,087,067 shares (+103.4%) to their portfolio in Q3 2025, for an estimated $100,412,378
• VICTORY CAPITAL MANAGEMENT INC removed 519,704 shares (-42.1%) from their portfolio in Q3 2025, for an estimated $48,005,058
• WATERFORD ADVISORS, LLC removed 299,586 shares (-99.0%) from their portfolio in Q3 2025, for an estimated $27,672,758
• YAUPON CAPITAL MANAGEMENT LP removed 294,684 shares (-62.3%) from their portfolio in Q3 2025, for an estimated $27,219,961
• BLACKROCK, INC. added 257,158 shares (+3.0%) to their portfolio in Q3 2025, for an estimated $23,753,684
• SQUAREPOINT OPS LLC added 250,130 shares (+428.8%) to their portfolio in Q3 2025, for an estimated $23,104,508
• WESTWOOD HOLDINGS GROUP INC added 249,032 shares (+inf%) to their portfolio in Q3 2025, for an estimated $23,003,085

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$410,000 of THE MOSAIC COMPANY lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Critical minerals PERMIT Act (HR3898); Maintaining Cooperative Permitting Act (S. 1014/HR3898) Legal trade remedies Federal tax code"

You can find more data on corporate lobbying on Quiver Quantitative.

MOS Congressional Stock Trading

Members of Congress have traded $MOS stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MOS stock by members of Congress over the last 6 months:

• REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MOS Insider Trading Activity

MOS insiders have traded $MOS stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MOS stock by insiders over the last 6 months:

• JODY LYNNE KUZENKO purchased 685 shares for an estimated $17,488

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MOS Hedge Fund Activity

We have seen 358 institutional investors add shares of MOS stock to their portfolio, and 359 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 16,035,052 shares (+76.5%) to their portfolio in Q3 2025, for an estimated $556,095,603
• AQR CAPITAL MANAGEMENT LLC added 7,294,205 shares (+632.6%) to their portfolio in Q3 2025, for an estimated $252,963,029
• BOSTON PARTNERS removed 6,648,109 shares (-89.7%) from their portfolio in Q3 2025, for an estimated $230,556,420
• BANK OF NEW YORK MELLON CORP added 3,894,947 shares (+102.3%) to their portfolio in Q3 2025, for an estimated $135,076,761
• D. E. SHAW & CO., INC. removed 2,909,883 shares (-39.2%) from their portfolio in Q3 2025, for an estimated $100,914,742
• FULLER & THALER ASSET MANAGEMENT, INC. removed 2,217,861 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $76,915,419
• MILLENNIUM MANAGEMENT LLC removed 1,895,347 shares (-76.1%) from their portfolio in Q3 2025, for an estimated $65,730,633

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MOS Analyst Ratings

Wall Street analysts have issued reports on $MOS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 01/12/2026
• Barclays issued a "Overweight" rating on 11/13/2025
• JP Morgan issued a "Overweight" rating on 08/11/2025

To track analyst ratings and price targets for MOS, check out Quiver Quantitative's $MOS forecast page.

MOS Price Targets

Multiple analysts have issued price targets for $MOS recently. We have seen 13 analysts offer price targets for $MOS in the last 6 months, with a median target of $32.0.

Here are some recent targets:

• Michael Sison from Wells Fargo set a target price of $27.0 on 01/23/2026
• Andrew D. Wong from RBC Capital set a target price of $29.0 on 01/20/2026
• Nigel Dally from Morgan Stanley set a target price of $35.0 on 01/14/2026
• Lucas Beaumont from UBS set a target price of $33.0 on 01/12/2026
• Christopher Parkinson from Mizuho set a target price of $28.0 on 12/18/2025
• Benjamin Theurer from Barclays set a target price of $31.0 on 12/09/2025
• Jeffrey Zekaukas from JP Morgan set a target price of $24.0 on 12/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$22,500 of 908 DEVICES INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY26 CJS Appropriations - Law Enforcement Funding FY26 DOD Appropriations - Air Force and Navy Funding Border Technology Funding Navy and Air Force Technology Funding Law Enforcement Funding"

You can find more data on corporate lobbying on Quiver Quantitative.

MASS Insider Trading Activity

MASS insiders have traded $MASS stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MASS stock by insiders over the last 6 months:

• JOSEPH H. IV GRIFFITH (Chief Financial Officer) has made 0 purchases and 3 sales selling 10,000 shares for an estimated $80,585.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MASS Hedge Fund Activity

We have seen 47 institutional investors add shares of MASS stock to their portfolio, and 52 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST LIGHT ASSET MANAGEMENT, LLC added 1,442,883 shares (+135.2%) to their portfolio in Q3 2025, for an estimated $12,639,655
• ARK INVESTMENT MANAGEMENT LLC removed 694,506 shares (-26.2%) from their portfolio in Q3 2025, for an estimated $6,083,872
• GM ADVISORY GROUP, LLC removed 487,205 shares (-41.8%) from their portfolio in Q3 2025, for an estimated $4,267,915
• FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 336,584 shares (+125.9%) to their portfolio in Q3 2025, for an estimated $2,948,475
• MARSHALL WACE, LLP removed 209,157 shares (-32.2%) from their portfolio in Q3 2025, for an estimated $1,832,215
• RAYMOND JAMES FINANCIAL INC added 176,616 shares (+2649.5%) to their portfolio in Q3 2025, for an estimated $1,547,156
• D. E. SHAW & CO., INC. removed 160,612 shares (-86.3%) from their portfolio in Q3 2025, for an estimated $1,406,961

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MASS Analyst Ratings

Wall Street analysts have issued reports on $MASS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Leerink Partners issued a "Outperform" rating on 08/05/2025

To track analyst ratings and price targets for MASS, check out Quiver Quantitative's $MASS forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$52,500 of LIGHTBRIDGE CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocate for the adoption of Lightbridges technology for disposition of plutonium from weapons in nuclear power reactors and for the use of their fuel in nuclear powered icebreakers. Advocate for an amendment to the ADVANCE Act."

You can find more data on corporate lobbying on Quiver Quantitative.

LTBR Insider Trading Activity

LTBR insiders have traded $LTBR stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $LTBR stock by insiders over the last 6 months:

• SETH GRAE (President and CEO) has made 0 purchases and 3 sales selling 60,512 shares for an estimated $1,639,152.
• ANDREY MUSHAKOV (EVP, Nuclear Operations) has made 0 purchases and 2 sales selling 42,691 shares for an estimated $981,494.
• LARRY GOLDMAN (CFO) has made 0 purchases and 6 sales selling 51,211 shares for an estimated $886,560.
• SWETA CHAKRABORTY has made 0 purchases and 6 sales selling 29,037 shares for an estimated $481,182.
• JESSE L. FUNCHES has made 0 purchases and 2 sales selling 2,897 shares for an estimated $57,398.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

LTBR Hedge Fund Activity

We have seen 70 institutional investors add shares of LTBR stock to their portfolio, and 27 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• SUSQUEHANNA INTERNATIONAL GROUP, LLP added 578,530 shares (+2541.0%) to their portfolio in Q3 2025, for an estimated $12,270,621
• AMERIPRISE FINANCIAL INC added 563,516 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,952,174
• SCULPTOR CAPITAL LP removed 355,500 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $7,540,155
• BLACKROCK, INC. added 346,047 shares (+30.2%) to their portfolio in Q3 2025, for an estimated $7,339,656
• CITADEL ADVISORS LLC added 323,688 shares (+905.5%) to their portfolio in Q3 2025, for an estimated $6,865,422
• BNP PARIBAS FINANCIAL MARKETS added 312,605 shares (+168.2%) to their portfolio in Q3 2025, for an estimated $6,630,352
• AROSA CAPITAL MANAGEMENT LP removed 300,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,363,000

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of BENTLEY SYSTEMS lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Surface transportation reauthorization and appropriations."

You can find more data on corporate lobbying on Quiver Quantitative.

BSY Insider Trading Activity

BSY insiders have traded $BSY stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $BSY stock by insiders over the last 6 months:

• GREGORY S BENTLEY (Executive Chair & President) sold 37,160 shares for an estimated $2,037,575
• THOMAS F TRIMBACK (Chief Accounting Officer) sold 560 shares for an estimated $24,091
• DAVID R. SHAMAN (Chief Legal Officer) sold 400 shares for an estimated $23,700

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BSY Hedge Fund Activity

We have seen 238 institutional investors add shares of BSY stock to their portfolio, and 222 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 2,931,296 shares (+inf%) to their portfolio in Q3 2025, for an estimated $150,903,118
• MANNING & NAPIER ADVISORS LLC added 2,347,598 shares (+inf%) to their portfolio in Q3 2025, for an estimated $120,854,345
• VANGUARD GROUP INC added 1,792,591 shares (+10.7%) to their portfolio in Q3 2025, for an estimated $92,282,584
• AXA S.A. removed 1,545,265 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $79,550,242
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 984,753 shares (+85.8%) to their portfolio in Q3 2025, for an estimated $50,695,084
• PICTET ASSET MANAGEMENT HOLDING SA removed 658,823 shares (-17.8%) from their portfolio in Q3 2025, for an estimated $33,916,208
• BESSEMER GROUP INC added 534,776 shares (+27.4%) to their portfolio in Q3 2025, for an estimated $27,530,268

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BSY Analyst Ratings

Wall Street analysts have issued reports on $BSY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 01/22/2026
• Rosenblatt issued a "Buy" rating on 11/06/2025
• Baird issued a "Outperform" rating on 11/06/2025
• Piper Sandler issued a "Overweight" rating on 11/06/2025
• Oppenheimer issued a "Outperform" rating on 08/07/2025
• Goldman Sachs issued a "Sell" rating on 08/07/2025

To track analyst ratings and price targets for BSY, check out Quiver Quantitative's $BSY forecast page.

BSY Price Targets

Multiple analysts have issued price targets for $BSY recently. We have seen 10 analysts offer price targets for $BSY in the last 6 months, with a median target of $49.5.

Here are some recent targets:

• Daniel Jester from BMO Capital set a target price of $48.0 on 01/22/2026
• Kristen Owen from Oppenheimer set a target price of $53.0 on 01/20/2026
• Clarke Jeffries from Piper Sandler set a target price of $45.0 on 01/13/2026
• Guy Hardwick from Barclays set a target price of $47.0 on 01/12/2026
• Matthew Hedberg from RBC Capital set a target price of $48.0 on 01/05/2026
• Alexei Gogolev from JP Morgan set a target price of $51.0 on 11/06/2025
• Blair Abernethy from Rosenblatt set a target price of $58.0 on 11/06/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$30,000 of ENVIRI CORPORATION (FORMERLY HARSCO CORPORATION) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"IIJA reauthorization and appropriations"

You can find more data on corporate lobbying on Quiver Quantitative.

NVRI Insider Trading Activity

NVRI insiders have traded $NVRI stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NVRI stock by insiders over the last 6 months:

• JENNIFER OTT KOZAK (Senior Vice President & CHRO) sold 9,692 shares for an estimated $176,197

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NVRI Hedge Fund Activity

We have seen 92 institutional investors add shares of NVRI stock to their portfolio, and 92 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 4,561,968 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $57,891,373
• PERTENTO PARTNERS LLP added 3,431,188 shares (+inf%) to their portfolio in Q3 2025, for an estimated $43,541,775
• SHAY CAPITAL LLC added 1,940,000 shares (+2939.4%) to their portfolio in Q3 2025, for an estimated $24,618,600
• DAVIDSON KEMPNER CAPITAL MANAGEMENT LP added 1,683,800 shares (+inf%) to their portfolio in Q3 2025, for an estimated $21,367,422
• MILLENNIUM MANAGEMENT LLC added 1,318,833 shares (+4621.0%) to their portfolio in Q3 2025, for an estimated $16,735,990
• SCOPIA CAPITAL MANAGEMENT LP added 953,281 shares (+inf%) to their portfolio in Q3 2025, for an estimated $12,097,135
• HG VORA CAPITAL MANAGEMENT, LLC removed 775,000 shares (-22.1%) from their portfolio in Q3 2025, for an estimated $9,834,750

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.